GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Chd1
|
ENSRNOG00000014434 | chromodomain helicase DNA binding protein 1 |
Pml
|
ENSRNOG00000008400 | promyelocytic leukemia |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Pml | rn6_v1_chr8_-_63034226_63034226 | -0.45 | 3.6e-17 | Click! |
Chd1 | rn6_v1_chr1_+_57692836_57692983 | -0.31 | 2.3e-08 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_-_107009330 | 163.94 |
ENSRNOT00000074573
|
Kcnq3
|
potassium voltage-gated channel subfamily Q member 3 |
chr4_-_146016325 | 163.24 |
ENSRNOT00000067931
|
Atp2b2
|
ATPase plasma membrane Ca2+ transporting 2 |
chr4_-_71713063 | 153.71 |
ENSRNOT00000059447
|
Fam131b
|
family with sequence similarity 131, member B |
chr14_-_82048251 | 114.88 |
ENSRNOT00000074734
|
Nat8l
|
N-acetyltransferase 8-like |
chr14_-_78902063 | 114.44 |
ENSRNOT00000088469
|
Ppp2r2c
|
protein phosphatase 2, regulatory subunit B, gamma |
chr1_-_52544450 | 114.29 |
ENSRNOT00000043474
|
Pde10a
|
phosphodiesterase 10A |
chr5_-_82168347 | 103.00 |
ENSRNOT00000084959
ENSRNOT00000084147 |
Astn2
|
astrotactin 2 |
chr15_+_108908607 | 102.53 |
ENSRNOT00000089455
|
Zic2
|
Zic family member 2 |
chr19_-_57192095 | 102.42 |
ENSRNOT00000058080
|
Pgbd5
|
piggyBac transposable element derived 5 |
chr8_-_94564525 | 99.30 |
ENSRNOT00000084437
|
Snap91
|
synaptosomal-associated protein 91 |
chr9_+_73493027 | 97.25 |
ENSRNOT00000074427
ENSRNOT00000089478 |
Unc80
|
unc-80 homolog, NALCN activator |
chr15_+_15275541 | 94.73 |
ENSRNOT00000012153
|
Cadps
|
calcium dependent secretion activator |
chr4_+_146106386 | 94.41 |
ENSRNOT00000008342
|
Slc6a11
|
solute carrier family 6 member 11 |
chr15_+_344360 | 94.28 |
ENSRNOT00000077671
|
Kcnma1
|
potassium calcium-activated channel subfamily M alpha 1 |
chr7_-_121029754 | 94.10 |
ENSRNOT00000004703
|
Nptxr
|
neuronal pentraxin receptor |
chr6_+_64297888 | 93.85 |
ENSRNOT00000050222
ENSRNOT00000083088 ENSRNOT00000093147 |
Nrcam
|
neuronal cell adhesion molecule |
chr4_+_147037179 | 92.29 |
ENSRNOT00000011292
|
Syn2
|
synapsin II |
chr3_+_111597102 | 88.02 |
ENSRNOT00000081462
|
Tyro3
|
TYRO3 protein tyrosine kinase |
chr3_-_160301552 | 87.16 |
ENSRNOT00000014498
|
Rims4
|
regulating synaptic membrane exocytosis 4 |
chr14_-_86297623 | 85.92 |
ENSRNOT00000067162
ENSRNOT00000081607 ENSRNOT00000085265 |
Camk2b
|
calcium/calmodulin-dependent protein kinase II beta |
chr10_-_14056169 | 83.41 |
ENSRNOT00000017833
|
Syngr3
|
synaptogyrin 3 |
chr19_-_11669578 | 83.25 |
ENSRNOT00000026373
|
Gnao1
|
G protein subunit alpha o1 |
chr8_+_118333706 | 82.04 |
ENSRNOT00000028278
|
Cspg5
|
chondroitin sulfate proteoglycan 5 |
chr1_-_64405149 | 80.21 |
ENSRNOT00000089944
|
Cacng7
|
calcium voltage-gated channel auxiliary subunit gamma 7 |
chr14_+_87312203 | 78.62 |
ENSRNOT00000088032
|
Adcy1
|
adenylate cyclase 1 |
chr8_-_57255263 | 77.49 |
ENSRNOT00000028972
|
LOC100125362
|
hypothetical protein LOC100125362 |
chr18_+_39335377 | 77.04 |
ENSRNOT00000083642
ENSRNOT00000067262 ENSRNOT00000022530 |
Kcnn2
|
potassium calcium-activated channel subfamily N member 2 |
chr1_-_72727112 | 76.98 |
ENSRNOT00000031172
|
Brsk1
|
BR serine/threonine kinase 1 |
chr4_-_64831233 | 76.94 |
ENSRNOT00000079285
|
Dgki
|
diacylglycerol kinase, iota |
chr6_-_67085390 | 76.63 |
ENSRNOT00000083277
|
Nova1
|
NOVA alternative splicing regulator 1 |
chr8_+_119566509 | 75.92 |
ENSRNOT00000028633
|
Trank1
|
tetratricopeptide repeat and ankyrin repeat containing 1 |
chr4_-_157294047 | 75.55 |
ENSRNOT00000005601
|
Eno2
|
enolase 2 |
chr5_-_62621737 | 74.57 |
ENSRNOT00000011573
|
Gabbr2
|
gamma-aminobutyric acid type B receptor subunit 2 |
chr6_+_144384773 | 73.89 |
ENSRNOT00000006942
|
Ptprn2
|
protein tyrosine phosphatase, receptor type N2 |
chrX_+_17540458 | 73.01 |
ENSRNOT00000045710
|
Nudt11
|
nudix hydrolase 11 |
chr15_+_344685 | 72.58 |
ENSRNOT00000065542
ENSRNOT00000066928 |
Kcnma1
|
potassium calcium-activated channel subfamily M alpha 1 |
chrX_+_42558931 | 72.45 |
ENSRNOT00000044129
|
Ptchd1
|
patched domain containing 1 |
chr11_+_86512797 | 72.19 |
ENSRNOT00000051680
|
Gp1bb
|
glycoprotein Ib platelet beta subunit |
chr19_+_20607507 | 71.96 |
ENSRNOT00000000011
|
Cbln1
|
cerebellin 1 precursor |
chr2_-_148050423 | 71.14 |
ENSRNOT00000064506
ENSRNOT00000023469 |
LOC100909840
|
profilin-2-like |
chr7_+_78092037 | 70.72 |
ENSRNOT00000050753
|
Rims2
|
regulating synaptic membrane exocytosis 2 |
chr5_-_58019836 | 70.58 |
ENSRNOT00000066977
|
Enho
|
energy homeostasis associated |
chr3_-_176644951 | 69.45 |
ENSRNOT00000049961
|
Kcnq2
|
potassium voltage-gated channel subfamily Q member 2 |
chr6_+_132246602 | 69.35 |
ENSRNOT00000009896
|
Cyp46a1
|
cytochrome P450, family 46, subfamily a, polypeptide 1 |
chr19_+_54553419 | 69.11 |
ENSRNOT00000025392
|
Jph3
|
junctophilin 3 |
chr4_-_64831473 | 68.85 |
ENSRNOT00000033268
|
Dgki
|
diacylglycerol kinase, iota |
chr11_+_83975367 | 68.65 |
ENSRNOT00000058131
|
Camk2n2
|
calcium/calmodulin-dependent protein kinase II inhibitor 2 |
chr5_+_156876706 | 67.97 |
ENSRNOT00000021864
|
Camk2n1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
chr13_+_92569785 | 67.09 |
ENSRNOT00000082700
|
Fmn2
|
formin 2 |
chrX_+_39711201 | 66.77 |
ENSRNOT00000080512
ENSRNOT00000009802 |
Cnksr2
|
connector enhancer of kinase suppressor of Ras 2 |
chr9_+_49479023 | 66.61 |
ENSRNOT00000050922
ENSRNOT00000077111 |
Pou3f3
|
POU class 3 homeobox 3 |
chr8_-_61290240 | 66.44 |
ENSRNOT00000023084
|
Lingo1
|
leucine rich repeat and Ig domain containing 1 |
chr3_+_154395187 | 66.20 |
ENSRNOT00000050810
|
Vstm2l
|
V-set and transmembrane domain containing 2 like |
chr17_+_41798783 | 66.13 |
ENSRNOT00000023519
|
Nrsn1
|
neurensin 1 |
chr14_-_78308933 | 65.16 |
ENSRNOT00000065334
|
Crmp1
|
collapsin response mediator protein 1 |
chr3_+_145032200 | 64.64 |
ENSRNOT00000068210
|
Syndig1
|
synapse differentiation inducing 1 |
chr1_-_261669584 | 63.87 |
ENSRNOT00000020568
ENSRNOT00000076555 |
Crtac1
|
cartilage acidic protein 1 |
chr2_-_119537837 | 63.69 |
ENSRNOT00000015200
|
Pex5l
|
peroxisomal biogenesis factor 5-like |
chr9_+_20251521 | 63.23 |
ENSRNOT00000005535
|
LOC100911625
|
gamma-enolase-like |
chr5_+_147323240 | 62.94 |
ENSRNOT00000047152
|
Fndc5
|
fibronectin type III domain containing 5 |
chr9_+_38297322 | 62.93 |
ENSRNOT00000078157
ENSRNOT00000088824 |
Bend6
|
BEN domain containing 6 |
chr3_+_155103150 | 62.76 |
ENSRNOT00000020720
|
Slc32a1
|
solute carrier family 32 member 1 |
chr4_+_438668 | 62.22 |
ENSRNOT00000008951
|
En2
|
engrailed homeobox 2 |
chr14_+_60764409 | 61.87 |
ENSRNOT00000005168
|
Lgi2
|
leucine-rich repeat LGI family, member 2 |
chr2_-_147959567 | 61.14 |
ENSRNOT00000063986
|
LOC100909840
|
profilin-2-like |
chr19_+_25526751 | 60.42 |
ENSRNOT00000083448
|
Cacna1a
|
calcium voltage-gated channel subunit alpha1 A |
chr2_-_187372652 | 60.36 |
ENSRNOT00000025496
ENSRNOT00000083116 |
Bcan
|
brevican |
chr7_+_128500011 | 59.77 |
ENSRNOT00000074625
|
Fam19a5
|
family with sequence similarity 19 member A5, C-C motif chemokine like |
chr3_+_152552822 | 59.70 |
ENSRNOT00000089719
|
Epb41l1
|
erythrocyte membrane protein band 4.1-like 1 |
chr2_-_179842547 | 59.18 |
ENSRNOT00000014170
|
Glrb
|
glycine receptor, beta |
chr6_-_99870024 | 59.08 |
ENSRNOT00000010043
|
Rab15
|
RAB15, member RAS oncogene family |
chr18_+_39172028 | 58.94 |
ENSRNOT00000086651
|
Kcnn2
|
potassium calcium-activated channel subfamily N member 2 |
chr7_+_70364813 | 58.82 |
ENSRNOT00000084012
ENSRNOT00000031230 |
Agap2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
chr1_-_101360971 | 57.64 |
ENSRNOT00000028164
|
Lin7b
|
lin-7 homolog B, crumbs cell polarity complex component |
chrX_-_95062132 | 57.56 |
ENSRNOT00000049956
|
Nap1l3
|
nucleosome assembly protein 1-like 3 |
chr3_+_79713567 | 57.48 |
ENSRNOT00000012110
|
C1qtnf4
|
C1q and tumor necrosis factor related protein 4 |
chr14_+_60123169 | 56.76 |
ENSRNOT00000006610
|
Sel1l3
|
SEL1L family member 3 |
chr20_-_47910375 | 56.59 |
ENSRNOT00000000348
|
Sobp
|
sine oculis binding protein homolog |
chr3_+_6773813 | 56.59 |
ENSRNOT00000065953
ENSRNOT00000013443 |
Olfm1
|
olfactomedin 1 |
chr1_+_80195532 | 56.57 |
ENSRNOT00000022528
|
Rtn2
|
reticulon 2 |
chrX_-_142131545 | 56.51 |
ENSRNOT00000077402
|
Fgf13
|
fibroblast growth factor 13 |
chr10_+_39655455 | 56.28 |
ENSRNOT00000058817
|
Acsl6
|
acyl-CoA synthetase long-chain family member 6 |
chr14_-_85191557 | 55.61 |
ENSRNOT00000011604
|
Nefh
|
neurofilament heavy |
chr10_+_67862054 | 55.21 |
ENSRNOT00000031746
|
Cdk5r1
|
cyclin-dependent kinase 5 regulatory subunit 1 |
chr6_-_98157087 | 54.99 |
ENSRNOT00000013275
|
Kcnh5
|
potassium voltage-gated channel subfamily H member 5 |
chr3_-_10602672 | 54.54 |
ENSRNOT00000011648
|
Ncs1
|
neuronal calcium sensor 1 |
chr5_-_151709877 | 54.06 |
ENSRNOT00000080602
|
Trnp1
|
TMF1-regulated nuclear protein 1 |
chr1_-_270472866 | 54.06 |
ENSRNOT00000015979
|
Sorcs1
|
sortilin-related VPS10 domain containing receptor 1 |
chr7_-_59514939 | 53.92 |
ENSRNOT00000085579
|
Kcnmb4
|
potassium calcium-activated channel subfamily M regulatory beta subunit 4 |
chr8_-_58542844 | 53.56 |
ENSRNOT00000012041
|
Elmod1
|
ELMO domain containing 1 |
chr10_-_74679858 | 53.48 |
ENSRNOT00000003859
|
Ppm1e
|
protein phosphatase, Mg2+/Mn2+ dependent, 1E |
chr10_-_82197848 | 53.18 |
ENSRNOT00000081307
|
Cacna1g
|
calcium voltage-gated channel subunit alpha1 G |
chr1_-_211923929 | 52.41 |
ENSRNOT00000054887
|
Nkx6-2
|
NK6 homeobox 2 |
chr4_+_13405136 | 51.66 |
ENSRNOT00000091004
|
Gnai1
|
G protein subunit alpha i1 |
chr3_+_161425988 | 51.66 |
ENSRNOT00000065184
|
Slc12a5
|
solute carrier family 12 member 5 |
chr14_+_77380262 | 51.31 |
ENSRNOT00000008030
|
Nsg1
|
neuron specific gene family member 1 |
chr2_-_229718659 | 50.65 |
ENSRNOT00000012676
|
Ugt8
|
UDP glycosyltransferase 8 |
chr16_-_62483137 | 50.57 |
ENSRNOT00000020683
|
Purg
|
purine-rich element binding protein G |
chr4_-_16130848 | 50.51 |
ENSRNOT00000042914
|
Cacna2d1
|
calcium voltage-gated channel auxiliary subunit alpha2delta 1 |
chr1_+_100297152 | 50.50 |
ENSRNOT00000026100
|
Shank1
|
SH3 and multiple ankyrin repeat domains 1 |
chr3_-_176816114 | 50.28 |
ENSRNOT00000079262
ENSRNOT00000018697 |
Stmn3
|
stathmin 3 |
chr6_+_105364668 | 49.89 |
ENSRNOT00000009513
ENSRNOT00000087090 |
Ttc9
|
tetratricopeptide repeat domain 9 |
chr4_+_142453013 | 49.43 |
ENSRNOT00000056573
|
AABR07061755.1
|
|
chr9_+_17841410 | 49.12 |
ENSRNOT00000031706
|
Tmem151b
|
transmembrane protein 151B |
chr1_-_212622537 | 49.06 |
ENSRNOT00000025609
|
Sprn
|
shadow of prion protein homolog (zebrafish) |
chrX_+_157150655 | 48.96 |
ENSRNOT00000090795
|
Pnck
|
pregnancy up-regulated nonubiquitous CaM kinase |
chr10_-_38838272 | 48.69 |
ENSRNOT00000089495
|
Sowaha
|
sosondowah ankyrin repeat domain family member A |
chr18_-_17716880 | 48.37 |
ENSRNOT00000061151
|
Celf4
|
CUGBP, Elav-like family member 4 |
chr2_-_77632628 | 48.25 |
ENSRNOT00000073915
|
Basp1
|
brain abundant, membrane attached signal protein 1 |
chr20_-_1984737 | 48.19 |
ENSRNOT00000040232
ENSRNOT00000051634 ENSRNOT00000079445 |
Gabbr1
|
gamma-aminobutyric acid type B receptor subunit 1 |
chr4_-_16130563 | 48.00 |
ENSRNOT00000090240
ENSRNOT00000034969 |
Cacna2d1
|
calcium voltage-gated channel auxiliary subunit alpha2delta 1 |
chr2_-_210241455 | 47.91 |
ENSRNOT00000086420
|
Kcnc4
|
potassium voltage-gated channel subfamily C member 4 |
chr15_+_19547871 | 47.69 |
ENSRNOT00000036235
|
Gpr137c
|
G protein-coupled receptor 137C |
chr3_-_1924827 | 47.64 |
ENSRNOT00000006162
|
Cacna1b
|
calcium voltage-gated channel subunit alpha1 B |
chr9_-_28972835 | 47.29 |
ENSRNOT00000086967
ENSRNOT00000079684 |
Rims1
|
regulating synaptic membrane exocytosis 1 |
chr4_+_22445414 | 46.93 |
ENSRNOT00000087657
ENSRNOT00000030224 |
Rundc3b
|
RUN domain containing 3B |
chr7_+_145117951 | 46.87 |
ENSRNOT00000055272
|
Pde1b
|
phosphodiesterase 1B |
chrX_-_106558366 | 46.79 |
ENSRNOT00000042126
|
Bex2
|
brain expressed X-linked 2 |
chr14_-_80732010 | 46.78 |
ENSRNOT00000012322
|
Adra2c
|
adrenoceptor alpha 2C |
chr8_+_59900651 | 46.74 |
ENSRNOT00000020410
|
Tmem266
|
transmembrane protein 266 |
chr5_-_109621170 | 46.37 |
ENSRNOT00000093007
|
Elavl2
|
ELAV like RNA binding protein 2 |
chr7_+_54980120 | 46.30 |
ENSRNOT00000005690
ENSRNOT00000005773 |
Kcnc2
|
potassium voltage-gated channel subfamily C member 2 |
chrX_-_118615798 | 46.21 |
ENSRNOT00000045463
|
Lrch2
|
leucine rich repeats and calponin homology domain containing 2 |
chr7_-_50638798 | 46.09 |
ENSRNOT00000048880
|
Syt1
|
synaptotagmin 1 |
chr1_-_198454914 | 45.64 |
ENSRNOT00000049044
|
Prrt2
|
proline-rich transmembrane protein 2 |
chr10_-_108691367 | 45.01 |
ENSRNOT00000005067
|
Nptx1
|
neuronal pentraxin 1 |
chr9_-_94601852 | 44.74 |
ENSRNOT00000022485
|
Ngef
|
neuronal guanine nucleotide exchange factor |
chr6_+_92229686 | 44.56 |
ENSRNOT00000046085
|
Atl1
|
atlastin GTPase 1 |
chr20_+_11972381 | 44.48 |
ENSRNOT00000001642
|
Adarb1
|
adenosine deaminase, RNA-specific, B1 |
chr4_-_153028129 | 44.24 |
ENSRNOT00000074558
|
Cecr6
|
cat eye syndrome chromosome region, candidate 6 |
chr18_+_30172740 | 44.03 |
ENSRNOT00000027340
|
Pcdha4
|
protocadherin alpha 4 |
chr6_+_26642783 | 43.80 |
ENSRNOT00000008126
|
Slc30a3
|
solute carrier family 30 member 3 |
chr2_+_78825074 | 43.67 |
ENSRNOT00000032027
|
March11
|
membrane associated ring-CH-type finger 11 |
chr2_+_241909832 | 43.44 |
ENSRNOT00000047975
|
Ppp3ca
|
protein phosphatase 3 catalytic subunit alpha |
chr4_+_132137793 | 43.41 |
ENSRNOT00000014455
|
Gpr27
|
G protein-coupled receptor 27 |
chrX_+_69580015 | 43.24 |
ENSRNOT00000057920
|
Fam155b
|
family with sequence similarity 155, member B |
chr2_+_198321142 | 42.91 |
ENSRNOT00000028760
|
Sv2a
|
synaptic vesicle glycoprotein 2a |
chr2_-_29768750 | 42.82 |
ENSRNOT00000023460
|
Map1b
|
microtubule-associated protein 1B |
chr7_+_11556192 | 42.78 |
ENSRNOT00000046078
|
Diras1
|
DIRAS family GTPase 1 |
chr1_+_78800754 | 42.76 |
ENSRNOT00000084601
|
Dact3
|
dishevelled-binding antagonist of beta-catenin 3 |
chr1_+_100447998 | 42.63 |
ENSRNOT00000026259
|
Lrrc4b
|
leucine rich repeat containing 4B |
chr5_+_148193710 | 42.54 |
ENSRNOT00000088568
|
Adgrb2
|
adhesion G protein-coupled receptor B2 |
chr3_+_110574417 | 42.31 |
ENSRNOT00000031231
|
Disp2
|
dispatched RND transporter family member 2 |
chr9_-_28973246 | 42.29 |
ENSRNOT00000091865
ENSRNOT00000015453 |
Rims1
|
regulating synaptic membrane exocytosis 1 |
chr7_+_130431213 | 42.25 |
ENSRNOT00000055792
|
Mapk8ip2
|
mitogen-activated protein kinase 8 interacting protein 2 |
chr10_-_83332851 | 42.09 |
ENSRNOT00000007133
|
Nxph3
|
neurexophilin 3 |
chr3_+_2262253 | 41.77 |
ENSRNOT00000042100
ENSRNOT00000061303 ENSRNOT00000048137 ENSRNOT00000048353 ENSRNOT00000012129 |
Nsmf
|
NMDA receptor synaptonuclear signaling and neuronal migration factor |
chr3_-_12944494 | 41.29 |
ENSRNOT00000023172
|
Mvb12b
|
multivesicular body subunit 12B |
chr4_-_120817377 | 41.27 |
ENSRNOT00000021826
|
Podxl2
|
podocalyxin-like 2 |
chr1_-_88908750 | 41.23 |
ENSRNOT00000028297
|
Aplp1
|
amyloid beta precursor like protein 1 |
chr10_-_76813386 | 41.17 |
ENSRNOT00000032388
|
Nog
|
noggin |
chr5_-_40237591 | 40.96 |
ENSRNOT00000011393
|
Fut9
|
fucosyltransferase 9 |
chr9_-_17114177 | 40.61 |
ENSRNOT00000061185
|
Lrrc73
|
leucine rich repeat containing 73 |
chr4_+_21317695 | 40.55 |
ENSRNOT00000007572
|
Grm3
|
glutamate metabotropic receptor 3 |
chr2_-_188645196 | 40.44 |
ENSRNOT00000083793
|
Efna3
|
ephrin A3 |
chr6_-_108415093 | 40.36 |
ENSRNOT00000031650
|
Syndig1l
|
synapse differentiation inducing 1-like |
chr3_-_176547965 | 40.34 |
ENSRNOT00000009041
|
Chrna4
|
cholinergic receptor nicotinic alpha 4 subunit |
chr2_+_22909569 | 40.32 |
ENSRNOT00000073871
|
Homer1
|
homer scaffolding protein 1 |
chr1_+_36185916 | 40.27 |
ENSRNOT00000041762
|
Ube2ql1
|
ubiquitin-conjugating enzyme E2Q family-like 1 |
chr16_-_5795825 | 40.13 |
ENSRNOT00000048043
|
Cacna2d3
|
calcium voltage-gated channel auxiliary subunit alpha2delta 3 |
chr17_+_21382455 | 40.08 |
ENSRNOT00000019756
|
Elovl2
|
ELOVL fatty acid elongase 2 |
chr15_-_44860604 | 40.07 |
ENSRNOT00000018637
|
Nefm
|
neurofilament medium |
chr3_-_176548208 | 40.04 |
ENSRNOT00000084339
|
Chrna4
|
cholinergic receptor nicotinic alpha 4 subunit |
chr5_-_74029238 | 40.04 |
ENSRNOT00000031432
|
Frrs1l
|
ferric-chelate reductase 1-like |
chr17_+_10384511 | 39.87 |
ENSRNOT00000024357
|
Sncb
|
synuclein, beta |
chr3_+_56861396 | 39.85 |
ENSRNOT00000000008
ENSRNOT00000084375 |
Gad1
|
glutamate decarboxylase 1 |
chr11_-_87017115 | 39.78 |
ENSRNOT00000051037
|
Rtn4r
|
reticulon 4 receptor |
chr9_-_92291220 | 39.67 |
ENSRNOT00000093357
|
Dner
|
delta/notch-like EGF repeat containing |
chrX_-_123515720 | 39.30 |
ENSRNOT00000092343
|
Nkrf
|
NFKB repressing factor |
chr8_+_22050222 | 39.17 |
ENSRNOT00000028096
|
Icam5
|
intercellular adhesion molecule 5 |
chr8_-_23063041 | 38.79 |
ENSRNOT00000018416
|
Elavl3
|
ELAV like RNA binding protein 3 |
chr20_-_6500523 | 38.35 |
ENSRNOT00000000629
|
Cpne5
|
copine 5 |
chr13_-_91872954 | 38.17 |
ENSRNOT00000004613
ENSRNOT00000079263 |
Cadm3
|
cell adhesion molecule 3 |
chr5_+_127404450 | 37.95 |
ENSRNOT00000017575
|
Lrp8
|
LDL receptor related protein 8 |
chr3_+_151310598 | 37.88 |
ENSRNOT00000092194
|
Mmp24
|
matrix metallopeptidase 24 |
chr5_-_142857131 | 37.65 |
ENSRNOT00000038055
|
Maneal
|
mannosidase, endo-alpha-like |
chr10_-_85974644 | 37.61 |
ENSRNOT00000006098
ENSRNOT00000082974 |
Cacnb1
|
calcium voltage-gated channel auxiliary subunit beta 1 |
chr1_+_221792221 | 37.48 |
ENSRNOT00000054828
|
Nrxn2
|
neurexin 2 |
chr19_-_26053762 | 37.41 |
ENSRNOT00000004646
|
MAST1
|
microtubule associated serine/threonine kinase 1 |
chr1_+_84470829 | 37.41 |
ENSRNOT00000025472
|
Ttc9b
|
tetratricopeptide repeat domain 9B |
chr3_-_54625414 | 37.29 |
ENSRNOT00000037133
|
Stk39
|
serine threonine kinase 39 |
chr1_+_101783621 | 37.02 |
ENSRNOT00000067679
|
Lmtk3
|
lemur tyrosine kinase 3 |
chr5_+_173183990 | 37.02 |
ENSRNOT00000068062
|
Tmem240
|
transmembrane protein 240 |
chr4_-_50860756 | 36.98 |
ENSRNOT00000068404
|
Cadps2
|
calcium dependent secretion activator 2 |
chr6_+_41917132 | 36.90 |
ENSRNOT00000071387
|
Ntsr2
|
neurotensin receptor 2 |
chrX_+_17171605 | 36.85 |
ENSRNOT00000048236
|
Nudt10
|
nudix (nucleoside diphosphate linked moiety X)-type motif 10 |
chr20_+_19318250 | 36.60 |
ENSRNOT00000000299
|
Phyhipl
|
phytanoyl-CoA 2-hydroxylase interacting protein-like |
chr1_+_105349069 | 36.60 |
ENSRNOT00000056030
|
Nell1
|
neural EGFL like 1 |
chr10_-_68517564 | 36.58 |
ENSRNOT00000086961
|
Asic2
|
acid sensing ion channel subunit 2 |
chr19_+_52086325 | 36.48 |
ENSRNOT00000020341
|
Necab2
|
N-terminal EF-hand calcium binding protein 2 |
chr18_-_63357194 | 35.99 |
ENSRNOT00000089408
ENSRNOT00000066103 |
Spire1
|
spire-type actin nucleation factor 1 |
chr2_+_102685513 | 35.98 |
ENSRNOT00000033940
|
Bhlhe22
|
basic helix-loop-helix family, member e22 |
chr2_-_172459165 | 35.87 |
ENSRNOT00000057473
|
Schip1
|
schwannomin interacting protein 1 |
chr2_+_115678344 | 35.86 |
ENSRNOT00000036717
|
Slc7a14
|
solute carrier family 7, member 14 |
chr1_-_103256823 | 35.79 |
ENSRNOT00000018860
|
Ptpn5
|
protein tyrosine phosphatase, non-receptor type 5 |
chr2_+_3400977 | 35.73 |
ENSRNOT00000093593
|
Mctp1
|
multiple C2 and transmembrane domain containing 1 |
chr8_+_117620317 | 35.59 |
ENSRNOT00000084220
|
Celsr3
|
cadherin, EGF LAG seven-pass G-type receptor 3 |
chr11_+_86516390 | 35.22 |
ENSRNOT00000041168
|
Gp1bb
|
glycoprotein Ib platelet beta subunit |
chr1_+_213870502 | 35.07 |
ENSRNOT00000086483
|
B4galnt4
|
beta-1,4-N-acetyl-galactosaminyl transferase 4 |
chr2_+_207923775 | 35.05 |
ENSRNOT00000019997
ENSRNOT00000051835 |
Kcnd3
|
potassium voltage-gated channel subfamily D member 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
55.6 | 166.9 | GO:0060082 | eye blink reflex(GO:0060082) |
44.7 | 134.1 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
36.4 | 145.5 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
34.4 | 137.7 | GO:0021586 | pons maturation(GO:0021586) |
31.9 | 95.7 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
29.9 | 89.6 | GO:0031632 | positive regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031632) |
28.6 | 85.9 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
26.5 | 106.0 | GO:1901909 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
26.4 | 211.0 | GO:0046959 | habituation(GO:0046959) |
24.5 | 73.4 | GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
23.4 | 70.3 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
23.1 | 69.3 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
21.5 | 128.8 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
21.4 | 85.6 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
21.3 | 127.8 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
21.2 | 63.7 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
21.1 | 42.2 | GO:0046958 | nonassociative learning(GO:0046958) |
20.1 | 160.6 | GO:0048840 | otolith development(GO:0048840) |
19.8 | 138.9 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
19.7 | 59.2 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
19.3 | 115.9 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
18.4 | 36.9 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
18.4 | 110.5 | GO:0023041 | neuronal signal transduction(GO:0023041) |
18.2 | 54.7 | GO:0051867 | general adaptation syndrome, behavioral process(GO:0051867) |
17.7 | 35.4 | GO:0099628 | receptor diffusion trapping(GO:0098953) postsynaptic neurotransmitter receptor diffusion trapping(GO:0098970) neurotransmitter receptor diffusion trapping(GO:0099628) protein localization to postsynaptic specialization membrane(GO:0099633) neurotransmitter receptor localization to postsynaptic specialization membrane(GO:0099645) |
17.7 | 17.7 | GO:0097213 | regulation of lysosomal membrane permeability(GO:0097213) positive regulation of lysosomal membrane permeability(GO:0097214) |
17.4 | 52.1 | GO:0061744 | motor behavior(GO:0061744) |
17.0 | 221.0 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
16.8 | 67.1 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
16.7 | 50.1 | GO:1905006 | negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905006) |
16.5 | 131.7 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
16.4 | 98.5 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
16.3 | 211.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
16.2 | 48.6 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
16.0 | 144.1 | GO:0061621 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
16.0 | 47.9 | GO:1904057 | negative regulation of sensory perception of pain(GO:1904057) |
15.8 | 63.1 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
15.6 | 62.5 | GO:0072021 | ascending thin limb development(GO:0072021) metanephric ascending thin limb development(GO:0072218) |
15.5 | 93.0 | GO:0021759 | globus pallidus development(GO:0021759) |
15.4 | 61.7 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
15.2 | 30.4 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
15.1 | 45.4 | GO:1903233 | positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) calcium ion import into sarcoplasmic reticulum(GO:1990036) |
15.1 | 302.3 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
14.8 | 44.5 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
14.7 | 73.5 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
14.4 | 43.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
14.3 | 28.6 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
14.0 | 28.0 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
13.9 | 41.7 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
13.7 | 96.2 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
13.4 | 40.2 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
13.3 | 13.3 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
13.1 | 78.8 | GO:0010045 | response to nickel cation(GO:0010045) |
13.0 | 26.0 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
12.9 | 64.4 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
12.8 | 282.5 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
12.4 | 37.3 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
12.1 | 36.2 | GO:0021898 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
11.9 | 71.4 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
11.9 | 71.2 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
11.8 | 35.5 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
11.6 | 34.9 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
11.6 | 34.7 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
11.3 | 33.8 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
11.1 | 89.2 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
11.0 | 296.7 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
10.8 | 21.5 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
10.7 | 64.4 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
10.4 | 20.9 | GO:0072197 | ureter morphogenesis(GO:0072197) |
10.3 | 41.3 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
10.3 | 30.9 | GO:0045959 | negative regulation of complement activation, classical pathway(GO:0045959) |
10.2 | 163.7 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
10.2 | 10.2 | GO:0036146 | cellular response to mycotoxin(GO:0036146) |
10.2 | 30.5 | GO:1990523 | bone regeneration(GO:1990523) |
10.0 | 110.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
9.9 | 69.6 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
9.9 | 29.8 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
9.9 | 29.8 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
9.8 | 19.7 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
9.7 | 68.1 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
9.7 | 67.7 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
9.6 | 154.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
9.6 | 28.7 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
9.5 | 19.0 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
9.5 | 19.0 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
9.4 | 18.8 | GO:1900453 | negative regulation of long term synaptic depression(GO:1900453) |
9.4 | 18.7 | GO:0007412 | axon target recognition(GO:0007412) |
9.3 | 18.6 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
9.3 | 27.8 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
9.1 | 128.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
9.1 | 36.6 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
9.1 | 45.3 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
8.8 | 8.8 | GO:0097104 | postsynaptic membrane assembly(GO:0097104) |
8.6 | 43.0 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
8.5 | 51.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
8.5 | 51.0 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
8.5 | 8.5 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
8.4 | 25.1 | GO:0035106 | operant conditioning(GO:0035106) |
8.3 | 83.2 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
8.3 | 307.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
8.2 | 32.8 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
8.0 | 40.1 | GO:0034626 | fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
7.9 | 87.4 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
7.9 | 23.8 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
7.9 | 23.8 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
7.9 | 63.2 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
7.8 | 265.6 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
7.8 | 23.3 | GO:0021578 | hindbrain maturation(GO:0021578) cerebellum maturation(GO:0021590) central nervous system maturation(GO:0021626) |
7.7 | 23.2 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
7.7 | 61.8 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
7.6 | 30.4 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
7.6 | 7.6 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
7.6 | 30.3 | GO:0098964 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
7.6 | 22.7 | GO:1990743 | protein sialylation(GO:1990743) |
7.5 | 60.2 | GO:1990034 | calcium ion export from cell(GO:1990034) |
7.5 | 22.5 | GO:1904700 | granulosa cell apoptotic process(GO:1904700) regulation of granulosa cell apoptotic process(GO:1904708) |
7.5 | 82.4 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
7.5 | 22.4 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) cerebral cortex GABAergic interneuron development(GO:0021894) |
7.4 | 44.7 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
7.4 | 51.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
7.4 | 103.8 | GO:0005513 | detection of calcium ion(GO:0005513) |
7.4 | 44.3 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
7.3 | 117.6 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
7.3 | 21.9 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
7.2 | 43.0 | GO:0021633 | optic nerve structural organization(GO:0021633) |
7.1 | 35.5 | GO:0061743 | motor learning(GO:0061743) |
7.1 | 21.2 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
7.0 | 7.0 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
7.0 | 20.9 | GO:0034486 | vacuolar transmembrane transport(GO:0034486) chaperone-mediated protein transport involved in chaperone-mediated autophagy(GO:0061741) |
6.9 | 20.8 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
6.9 | 20.7 | GO:0061642 | chemoattraction of axon(GO:0061642) renal outer medulla development(GO:0072054) |
6.9 | 20.7 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
6.9 | 27.5 | GO:0001552 | ovarian follicle atresia(GO:0001552) |
6.9 | 13.8 | GO:0032423 | regulation of mismatch repair(GO:0032423) |
6.8 | 20.4 | GO:0009098 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
6.8 | 20.3 | GO:0015820 | leucine transport(GO:0015820) |
6.8 | 60.9 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
6.8 | 47.3 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
6.7 | 20.1 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
6.7 | 33.4 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
6.6 | 79.0 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
6.6 | 39.4 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
6.6 | 32.8 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
6.4 | 19.2 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
6.2 | 12.4 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
6.2 | 18.6 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
6.2 | 43.3 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
6.1 | 24.5 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
6.1 | 18.3 | GO:0001994 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
6.1 | 18.3 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
6.0 | 60.4 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
6.0 | 29.8 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
5.9 | 53.4 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
5.9 | 290.0 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
5.9 | 11.8 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
5.8 | 17.5 | GO:0043474 | eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) rhodopsin metabolic process(GO:0046154) |
5.8 | 46.1 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
5.8 | 63.4 | GO:1990403 | embryonic brain development(GO:1990403) |
5.7 | 22.8 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
5.7 | 17.1 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
5.7 | 39.7 | GO:0007220 | Notch receptor processing(GO:0007220) |
5.5 | 11.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
5.5 | 11.1 | GO:1901629 | regulation of presynaptic membrane organization(GO:1901629) |
5.5 | 11.0 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
5.4 | 27.0 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
5.4 | 26.8 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
5.3 | 32.0 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
5.3 | 5.3 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
5.3 | 5.3 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
5.3 | 57.9 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
5.2 | 5.2 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
5.2 | 5.2 | GO:1901093 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
5.2 | 15.5 | GO:0050975 | sensory perception of touch(GO:0050975) |
5.1 | 368.9 | GO:0007269 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
5.1 | 25.5 | GO:0035063 | nuclear speck organization(GO:0035063) |
5.1 | 65.7 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
5.1 | 25.3 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
5.0 | 20.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
5.0 | 10.0 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
5.0 | 19.8 | GO:0035617 | stress granule disassembly(GO:0035617) |
4.9 | 24.7 | GO:0060023 | soft palate development(GO:0060023) |
4.9 | 74.1 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
4.9 | 69.1 | GO:0021794 | thalamus development(GO:0021794) |
4.9 | 14.7 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
4.9 | 49.0 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
4.9 | 9.8 | GO:1904207 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
4.9 | 174.8 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
4.8 | 24.0 | GO:1904647 | response to rotenone(GO:1904647) |
4.8 | 9.5 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
4.8 | 85.7 | GO:0021860 | pyramidal neuron development(GO:0021860) |
4.8 | 28.5 | GO:0035934 | corticosterone secretion(GO:0035934) |
4.7 | 18.9 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
4.7 | 18.6 | GO:0015746 | citrate transport(GO:0015746) |
4.6 | 23.0 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
4.5 | 27.1 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
4.5 | 9.0 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
4.4 | 13.3 | GO:0006543 | glutamine catabolic process(GO:0006543) |
4.4 | 13.2 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
4.4 | 4.4 | GO:1990379 | lipid transport across blood brain barrier(GO:1990379) |
4.3 | 13.0 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
4.3 | 39.1 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
4.3 | 34.7 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
4.3 | 26.0 | GO:0097120 | receptor localization to synapse(GO:0097120) |
4.3 | 12.9 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
4.3 | 12.9 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
4.3 | 21.3 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
4.3 | 51.1 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
4.2 | 8.5 | GO:0046038 | guanine salvage(GO:0006178) GMP catabolic process(GO:0046038) guanine biosynthetic process(GO:0046099) |
4.2 | 50.8 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
4.2 | 16.7 | GO:0007614 | short-term memory(GO:0007614) |
4.2 | 12.5 | GO:0010625 | positive regulation of Schwann cell proliferation(GO:0010625) |
4.1 | 16.5 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
4.0 | 16.2 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
4.0 | 28.3 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
4.0 | 12.1 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
4.0 | 16.0 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
4.0 | 23.8 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
4.0 | 7.9 | GO:1904954 | Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
4.0 | 7.9 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
3.9 | 15.8 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
3.9 | 11.8 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
3.9 | 3.9 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
3.9 | 58.2 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
3.8 | 196.1 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
3.8 | 76.5 | GO:0010107 | potassium ion import(GO:0010107) |
3.8 | 15.3 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
3.8 | 38.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
3.8 | 7.6 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
3.8 | 159.6 | GO:0021762 | substantia nigra development(GO:0021762) |
3.8 | 11.4 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
3.8 | 90.4 | GO:0008038 | neuron recognition(GO:0008038) |
3.8 | 15.1 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
3.7 | 18.7 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
3.7 | 7.5 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
3.7 | 18.3 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
3.6 | 7.3 | GO:0072300 | positive regulation of metanephric glomerulus development(GO:0072300) |
3.6 | 14.5 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
3.6 | 17.9 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
3.6 | 43.0 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
3.6 | 35.5 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
3.5 | 21.3 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
3.5 | 42.4 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
3.5 | 28.1 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
3.5 | 70.2 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
3.5 | 129.2 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
3.4 | 13.8 | GO:0042940 | D-amino acid transport(GO:0042940) |
3.4 | 6.9 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
3.4 | 6.8 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
3.4 | 44.1 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
3.4 | 13.5 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
3.4 | 20.3 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
3.4 | 13.5 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
3.4 | 20.3 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
3.4 | 3.4 | GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
3.4 | 6.7 | GO:0052572 | response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
3.4 | 10.1 | GO:0019417 | sulfur oxidation(GO:0019417) |
3.4 | 3.4 | GO:2000277 | positive regulation of oxidative phosphorylation uncoupler activity(GO:2000277) |
3.4 | 16.8 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
3.3 | 3.3 | GO:0071282 | cellular response to iron(II) ion(GO:0071282) |
3.2 | 45.5 | GO:0071625 | vocalization behavior(GO:0071625) |
3.2 | 12.6 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
3.2 | 3.2 | GO:0015827 | tryptophan transport(GO:0015827) |
3.1 | 3.1 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
3.1 | 18.6 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
3.1 | 12.2 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
3.0 | 30.3 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
3.0 | 3.0 | GO:0006598 | polyamine catabolic process(GO:0006598) |
3.0 | 21.1 | GO:0034650 | cortisol metabolic process(GO:0034650) cortisol biosynthetic process(GO:0034651) |
3.0 | 3.0 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
3.0 | 30.2 | GO:0008215 | spermine metabolic process(GO:0008215) |
3.0 | 12.0 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
3.0 | 3.0 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
3.0 | 8.9 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
3.0 | 8.9 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
3.0 | 23.8 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
3.0 | 11.8 | GO:1901423 | response to benzene(GO:1901423) |
2.9 | 20.6 | GO:0051775 | response to redox state(GO:0051775) |
2.9 | 11.6 | GO:1903525 | regulation of membrane tubulation(GO:1903525) positive regulation of membrane tubulation(GO:1903527) |
2.8 | 25.5 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
2.8 | 8.5 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
2.8 | 5.6 | GO:0070560 | protein secretion by platelet(GO:0070560) |
2.8 | 5.6 | GO:0051866 | general adaptation syndrome(GO:0051866) |
2.8 | 2.8 | GO:0051204 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) protein insertion into mitochondrial membrane(GO:0051204) |
2.8 | 8.4 | GO:0006589 | octopamine biosynthetic process(GO:0006589) octopamine metabolic process(GO:0046333) |
2.7 | 49.5 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
2.7 | 13.6 | GO:0033572 | transferrin transport(GO:0033572) |
2.7 | 18.9 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
2.7 | 13.5 | GO:0042756 | drinking behavior(GO:0042756) |
2.7 | 45.9 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
2.7 | 8.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
2.7 | 10.8 | GO:2001225 | regulation of chloride transport(GO:2001225) |
2.7 | 5.4 | GO:1904000 | carbohydrate utilization(GO:0009758) positive regulation of eating behavior(GO:1904000) |
2.7 | 10.7 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
2.7 | 10.7 | GO:1903056 | regulation of melanosome organization(GO:1903056) |
2.7 | 8.0 | GO:0016129 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
2.7 | 8.0 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
2.6 | 7.9 | GO:0071691 | cardiac muscle thin filament assembly(GO:0071691) |
2.6 | 10.5 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
2.6 | 12.9 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
2.6 | 10.3 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
2.6 | 10.3 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
2.6 | 2.6 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
2.5 | 22.9 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
2.5 | 7.6 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
2.5 | 7.5 | GO:0060988 | lipid tube assembly(GO:0060988) |
2.5 | 12.5 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
2.5 | 69.6 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
2.5 | 9.9 | GO:0032349 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
2.5 | 12.4 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
2.5 | 7.4 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
2.5 | 4.9 | GO:0003275 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
2.4 | 9.7 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
2.4 | 2.4 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
2.4 | 7.2 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
2.4 | 11.8 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
2.3 | 9.4 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
2.3 | 7.0 | GO:0071387 | cellular response to cortisol stimulus(GO:0071387) |
2.3 | 2.3 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
2.3 | 25.4 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
2.3 | 4.6 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
2.3 | 4.6 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
2.3 | 25.2 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
2.3 | 16.0 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
2.3 | 31.9 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
2.3 | 40.8 | GO:1905145 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
2.3 | 4.5 | GO:0051695 | actin filament uncapping(GO:0051695) |
2.3 | 18.0 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
2.2 | 18.0 | GO:0035524 | proline transport(GO:0015824) proline transmembrane transport(GO:0035524) |
2.2 | 6.7 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
2.2 | 11.2 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
2.2 | 4.5 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
2.2 | 6.7 | GO:1903445 | protein transport from ciliary membrane to plasma membrane(GO:1903445) |
2.2 | 13.4 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
2.2 | 4.5 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
2.2 | 6.7 | GO:0099612 | protein localization to axon(GO:0099612) |
2.2 | 6.6 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
2.2 | 2.2 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
2.2 | 6.5 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
2.2 | 4.3 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
2.2 | 19.4 | GO:0060384 | innervation(GO:0060384) |
2.2 | 25.9 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
2.1 | 19.3 | GO:0060074 | synapse maturation(GO:0060074) |
2.1 | 10.7 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
2.1 | 19.2 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
2.1 | 27.3 | GO:0016486 | peptide hormone processing(GO:0016486) |
2.1 | 41.7 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
2.1 | 10.4 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
2.1 | 12.4 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
2.1 | 14.5 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
2.1 | 4.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
2.0 | 4.1 | GO:1903541 | regulation of exosomal secretion(GO:1903541) |
2.0 | 8.1 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
2.0 | 6.1 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
2.0 | 6.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
2.0 | 6.0 | GO:0030043 | actin filament fragmentation(GO:0030043) |
2.0 | 2.0 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
2.0 | 10.0 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
2.0 | 6.0 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
2.0 | 2.0 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
2.0 | 5.9 | GO:0015942 | formate metabolic process(GO:0015942) |
2.0 | 47.1 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
1.9 | 5.8 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
1.9 | 5.8 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
1.9 | 7.8 | GO:2000327 | positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
1.9 | 36.6 | GO:0006836 | neurotransmitter transport(GO:0006836) |
1.9 | 19.3 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
1.9 | 5.7 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
1.9 | 32.4 | GO:0008210 | estrogen metabolic process(GO:0008210) |
1.9 | 9.5 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
1.9 | 18.9 | GO:0001967 | suckling behavior(GO:0001967) |
1.9 | 11.3 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
1.9 | 7.5 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
1.9 | 26.3 | GO:0035493 | SNARE complex assembly(GO:0035493) |
1.9 | 44.8 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
1.9 | 3.7 | GO:0030186 | melatonin metabolic process(GO:0030186) |
1.9 | 1.9 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
1.9 | 9.3 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
1.8 | 1.8 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
1.8 | 3.7 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
1.8 | 49.0 | GO:0019835 | cytolysis(GO:0019835) |
1.8 | 5.4 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
1.8 | 5.4 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
1.8 | 3.6 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
1.8 | 1.8 | GO:1904350 | regulation of protein catabolic process in the vacuole(GO:1904350) |
1.8 | 1.8 | GO:0042069 | regulation of catecholamine metabolic process(GO:0042069) |
1.8 | 26.8 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
1.8 | 41.0 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
1.8 | 8.9 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
1.8 | 7.1 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
1.8 | 7.1 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
1.8 | 1.8 | GO:0070904 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
1.8 | 1.8 | GO:0036334 | epidermal stem cell homeostasis(GO:0036334) |
1.8 | 7.0 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
1.8 | 12.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
1.8 | 10.5 | GO:0035372 | protein localization to microtubule(GO:0035372) |
1.8 | 5.3 | GO:0072033 | renal vesicle formation(GO:0072033) ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
1.7 | 10.5 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
1.7 | 24.4 | GO:0042417 | dopamine metabolic process(GO:0042417) |
1.7 | 50.6 | GO:0018345 | protein palmitoylation(GO:0018345) |
1.7 | 12.1 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
1.7 | 8.6 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
1.7 | 15.3 | GO:0001964 | startle response(GO:0001964) |
1.7 | 59.1 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
1.7 | 3.4 | GO:0016115 | sesquiterpenoid catabolic process(GO:0016107) terpenoid catabolic process(GO:0016115) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) |
1.7 | 6.7 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
1.7 | 31.8 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
1.7 | 8.3 | GO:0038203 | TORC2 signaling(GO:0038203) |
1.7 | 13.4 | GO:0046548 | retinal rod cell development(GO:0046548) |
1.7 | 6.7 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
1.7 | 5.0 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
1.7 | 10.0 | GO:0007097 | nuclear migration(GO:0007097) |
1.7 | 8.3 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
1.7 | 3.3 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.6 | 39.5 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
1.6 | 14.7 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
1.6 | 41.5 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
1.6 | 6.4 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
1.6 | 1.6 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
1.6 | 3.2 | GO:0060174 | limb bud formation(GO:0060174) |
1.6 | 4.7 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
1.6 | 21.9 | GO:0036065 | fucosylation(GO:0036065) |
1.6 | 20.3 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) |
1.6 | 7.8 | GO:0090383 | phagosome acidification(GO:0090383) |
1.5 | 18.5 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
1.5 | 1.5 | GO:1903093 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
1.5 | 15.4 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
1.5 | 10.7 | GO:0071318 | cellular response to ATP(GO:0071318) |
1.5 | 6.1 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
1.5 | 4.5 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
1.5 | 4.5 | GO:1900222 | regulation of beta-amyloid clearance(GO:1900221) negative regulation of beta-amyloid clearance(GO:1900222) |
1.5 | 6.0 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) |
1.5 | 4.5 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
1.5 | 4.5 | GO:0031645 | negative regulation of neurological system process(GO:0031645) |
1.5 | 3.0 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
1.5 | 3.0 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
1.5 | 14.7 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
1.5 | 4.4 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
1.5 | 35.1 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
1.5 | 2.9 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
1.5 | 2.9 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
1.4 | 1.4 | GO:1903297 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
1.4 | 21.3 | GO:0001675 | acrosome assembly(GO:0001675) |
1.4 | 269.1 | GO:0099537 | trans-synaptic signaling(GO:0099537) |
1.4 | 11.3 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
1.4 | 2.8 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) cell proliferation involved in embryonic placenta development(GO:0060722) |
1.4 | 9.9 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
1.4 | 2.8 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
1.4 | 12.7 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
1.4 | 82.5 | GO:0045921 | positive regulation of exocytosis(GO:0045921) |
1.4 | 18.1 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
1.4 | 8.3 | GO:0008090 | retrograde axonal transport(GO:0008090) |
1.4 | 8.2 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
1.4 | 4.1 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
1.3 | 12.1 | GO:0006465 | signal peptide processing(GO:0006465) |
1.3 | 2.7 | GO:0030913 | paranodal junction assembly(GO:0030913) |
1.3 | 4.0 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
1.3 | 11.9 | GO:0018095 | protein polyglutamylation(GO:0018095) |
1.3 | 5.3 | GO:0097332 | response to antipsychotic drug(GO:0097332) |
1.3 | 5.3 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
1.3 | 3.9 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
1.3 | 3.9 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
1.3 | 9.1 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
1.3 | 9.1 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
1.3 | 3.9 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
1.3 | 3.8 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
1.3 | 5.1 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
1.3 | 2.5 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
1.3 | 8.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
1.3 | 3.8 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
1.3 | 2.5 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
1.2 | 6.2 | GO:0061709 | reticulophagy(GO:0061709) |
1.2 | 27.1 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
1.2 | 14.8 | GO:0098743 | cell aggregation(GO:0098743) |
1.2 | 7.4 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
1.2 | 8.6 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
1.2 | 11.0 | GO:0070995 | NADPH oxidation(GO:0070995) |
1.2 | 2.4 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
1.2 | 3.6 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
1.2 | 2.4 | GO:0000022 | mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) mitotic spindle midzone assembly(GO:0051256) |
1.2 | 16.6 | GO:0045475 | locomotor rhythm(GO:0045475) |
1.2 | 16.4 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
1.2 | 4.7 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
1.2 | 67.5 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
1.2 | 2.3 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
1.2 | 3.5 | GO:1903575 | cornified envelope assembly(GO:1903575) |
1.1 | 10.2 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
1.1 | 2.3 | GO:0031133 | regulation of axon diameter(GO:0031133) |
1.1 | 14.7 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
1.1 | 2.2 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
1.1 | 1.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
1.1 | 21.9 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
1.1 | 1.1 | GO:0086013 | membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
1.1 | 2.2 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
1.1 | 2.2 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
1.1 | 6.5 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
1.1 | 4.3 | GO:0032264 | IMP salvage(GO:0032264) |
1.1 | 53.0 | GO:0065002 | intracellular protein transmembrane transport(GO:0065002) |
1.1 | 1.1 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
1.1 | 1.1 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) positive regulation of NAD(P)H oxidase activity(GO:0033864) |
1.1 | 2.1 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
1.1 | 4.2 | GO:0031585 | peptidyl-aspartic acid modification(GO:0018197) regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) peptidyl-aspartic acid hydroxylation(GO:0042264) |
1.1 | 6.3 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
1.0 | 2.1 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
1.0 | 3.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.0 | 5.2 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
1.0 | 2.1 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
1.0 | 3.1 | GO:0019389 | glucuronoside metabolic process(GO:0019389) |
1.0 | 6.0 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
1.0 | 2.0 | GO:0072198 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
1.0 | 28.7 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
1.0 | 5.9 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
1.0 | 9.8 | GO:0000338 | protein deneddylation(GO:0000338) |
1.0 | 2.9 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
1.0 | 3.8 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
1.0 | 1.9 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.9 | 2.8 | GO:0021678 | third ventricle development(GO:0021678) |
0.9 | 13.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.9 | 7.5 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.9 | 1.9 | GO:0060382 | regulation of DNA strand elongation(GO:0060382) |
0.9 | 4.7 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.9 | 6.6 | GO:0015791 | polyol transport(GO:0015791) |
0.9 | 13.1 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.9 | 7.5 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.9 | 13.0 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.9 | 3.7 | GO:0031179 | peptide modification(GO:0031179) |
0.9 | 0.9 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.9 | 4.6 | GO:0019563 | glycerol catabolic process(GO:0019563) |
0.9 | 2.8 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.9 | 36.4 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.9 | 7.2 | GO:0071501 | SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.9 | 4.5 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.9 | 2.7 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.9 | 13.5 | GO:0021696 | cerebellar cortex morphogenesis(GO:0021696) |
0.9 | 12.5 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
0.9 | 8.0 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.9 | 9.7 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.9 | 4.4 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.9 | 7.0 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.9 | 2.6 | GO:0097187 | dentinogenesis(GO:0097187) |
0.9 | 28.7 | GO:0007631 | feeding behavior(GO:0007631) |
0.9 | 20.8 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.9 | 2.6 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.8 | 2.5 | GO:0032095 | regulation of response to food(GO:0032095) negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
0.8 | 3.4 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.8 | 1.7 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.8 | 0.8 | GO:0018307 | enzyme active site formation(GO:0018307) |
0.8 | 4.2 | GO:0046725 | negative regulation by virus of viral protein levels in host cell(GO:0046725) |
0.8 | 1.7 | GO:0042350 | GDP-L-fucose biosynthetic process(GO:0042350) GDP-L-fucose metabolic process(GO:0046368) |
0.8 | 25.1 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.8 | 26.7 | GO:0007612 | learning(GO:0007612) |
0.8 | 14.1 | GO:1903432 | regulation of TORC1 signaling(GO:1903432) |
0.8 | 4.1 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.8 | 13.3 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.8 | 2.5 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.8 | 1.6 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.8 | 2.5 | GO:0045575 | basophil activation(GO:0045575) |
0.8 | 18.3 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.8 | 3.9 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.8 | 16.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.8 | 22.5 | GO:0051058 | negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.8 | 2.3 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.8 | 2.3 | GO:0051031 | tRNA export from nucleus(GO:0006409) tRNA transport(GO:0051031) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.8 | 73.3 | GO:0071804 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.7 | 17.2 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.7 | 2.2 | GO:0000962 | mitochondrial mRNA catabolic process(GO:0000958) positive regulation of mitochondrial RNA catabolic process(GO:0000962) RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) |
0.7 | 2.2 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
0.7 | 5.1 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.7 | 2.2 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.7 | 9.3 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.7 | 10.7 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.7 | 3.5 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.7 | 3.5 | GO:1901020 | negative regulation of calcium ion transmembrane transporter activity(GO:1901020) |
0.7 | 5.5 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.7 | 0.7 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.7 | 8.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.7 | 5.5 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.7 | 1.4 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
0.7 | 1.3 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.7 | 5.4 | GO:0015884 | folic acid transport(GO:0015884) |
0.7 | 3.3 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.7 | 6.6 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.7 | 10.0 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.7 | 6.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.7 | 2.0 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.6 | 1.3 | GO:2000813 | negative regulation of barbed-end actin filament capping(GO:2000813) |
0.6 | 1.9 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.6 | 1.9 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
0.6 | 3.2 | GO:0071104 | response to interleukin-9(GO:0071104) |
0.6 | 1.9 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.6 | 1.3 | GO:0035973 | aggrephagy(GO:0035973) |
0.6 | 3.8 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.6 | 16.4 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
0.6 | 56.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.6 | 3.7 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.6 | 0.6 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.6 | 7.2 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.6 | 1.8 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.6 | 5.9 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.6 | 5.8 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.6 | 1.2 | GO:0035635 | fucose metabolic process(GO:0006004) entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.6 | 4.0 | GO:0030803 | negative regulation of cyclic nucleotide biosynthetic process(GO:0030803) |
0.6 | 1.7 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.6 | 2.3 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.6 | 11.5 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.6 | 1.7 | GO:0060816 | random inactivation of X chromosome(GO:0060816) regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.6 | 2.3 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.6 | 1.7 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.6 | 2.2 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.5 | 2.2 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.5 | 5.9 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.5 | 1.6 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.5 | 3.8 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.5 | 4.3 | GO:0007041 | lysosomal transport(GO:0007041) |
0.5 | 1.1 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.5 | 0.5 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.5 | 2.6 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.5 | 9.8 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.5 | 0.5 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
0.5 | 5.6 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.5 | 1.5 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.5 | 2.0 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.5 | 8.2 | GO:0002347 | response to tumor cell(GO:0002347) |
0.5 | 1.0 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.5 | 8.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.5 | 12.6 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.5 | 14.5 | GO:0042446 | hormone biosynthetic process(GO:0042446) |
0.5 | 2.5 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.5 | 4.4 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.5 | 1.9 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.5 | 1.0 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.5 | 1.0 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
0.5 | 1.4 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
0.5 | 3.4 | GO:0051182 | coenzyme transport(GO:0051182) |
0.5 | 0.5 | GO:1990737 | negative regulation of translational initiation in response to stress(GO:0032057) response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
0.5 | 25.6 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.5 | 2.4 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.5 | 7.5 | GO:0097503 | sialylation(GO:0097503) |
0.5 | 2.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.5 | 5.0 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
0.4 | 0.9 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.4 | 2.2 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.4 | 4.4 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.4 | 1.7 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.4 | 0.4 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.4 | 0.8 | GO:1990792 | response to glial cell derived neurotrophic factor(GO:1990790) cellular response to glial cell derived neurotrophic factor(GO:1990792) |
0.4 | 1.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.4 | 8.3 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.4 | 1.2 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.4 | 0.4 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.4 | 8.6 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.4 | 2.8 | GO:0014002 | astrocyte development(GO:0014002) |
0.4 | 4.1 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.4 | 3.2 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.4 | 2.4 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.4 | 0.8 | GO:0097037 | heme export(GO:0097037) |
0.4 | 0.4 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.4 | 4.2 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.4 | 21.2 | GO:1990138 | neuron projection extension(GO:1990138) |
0.4 | 2.6 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.4 | 4.1 | GO:0051601 | exocyst localization(GO:0051601) |
0.4 | 1.5 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.4 | 0.7 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.4 | 0.7 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.4 | 5.6 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.3 | 1.4 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.3 | 2.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.3 | 1.4 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.3 | 1.4 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
0.3 | 3.7 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.3 | 2.4 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.3 | 2.0 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.3 | 14.7 | GO:0022900 | electron transport chain(GO:0022900) |
0.3 | 4.2 | GO:0007416 | synapse assembly(GO:0007416) |
0.3 | 1.3 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.3 | 3.9 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.3 | 0.6 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.3 | 2.8 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.3 | 4.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.3 | 4.3 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.3 | 2.1 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.3 | 2.1 | GO:0030575 | nuclear body organization(GO:0030575) |
0.3 | 5.0 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.3 | 2.0 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
0.3 | 0.6 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.3 | 1.1 | GO:0036337 | Fas signaling pathway(GO:0036337) |
0.3 | 1.1 | GO:0097032 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.3 | 1.1 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.3 | 0.8 | GO:0051697 | protein delipidation(GO:0051697) |
0.3 | 1.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.3 | 0.8 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.3 | 1.5 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.3 | 1.8 | GO:0015747 | urate transport(GO:0015747) |
0.2 | 1.0 | GO:1904179 | regulation of adipose tissue development(GO:1904177) positive regulation of adipose tissue development(GO:1904179) |
0.2 | 2.4 | GO:0006828 | manganese ion transport(GO:0006828) |
0.2 | 0.7 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.2 | 0.7 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.2 | 0.9 | GO:0052651 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
0.2 | 0.5 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) regulation of skeletal muscle hypertrophy(GO:1904204) |
0.2 | 1.3 | GO:0034184 | positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.2 | 0.9 | GO:0090042 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.2 | 0.8 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
0.2 | 7.5 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.2 | 0.4 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.2 | 1.8 | GO:0006968 | cellular defense response(GO:0006968) |
0.2 | 0.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.2 | 2.9 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.2 | 1.0 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.2 | 0.6 | GO:0036451 | cap mRNA methylation(GO:0036451) |
0.2 | 1.1 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
0.2 | 0.9 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.2 | 0.7 | GO:0010999 | regulation of eIF2 alpha phosphorylation by heme(GO:0010999) |
0.2 | 0.9 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.2 | 0.5 | GO:0006567 | threonine catabolic process(GO:0006567) |
0.2 | 0.4 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.2 | 0.9 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.2 | 0.5 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.2 | 1.3 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.2 | 0.3 | GO:0018410 | C-terminal protein amino acid modification(GO:0018410) |
0.2 | 0.5 | GO:0006431 | methionyl-tRNA aminoacylation(GO:0006431) |
0.2 | 8.0 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.2 | 2.8 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.2 | 1.7 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.2 | 2.6 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.2 | 0.9 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.2 | 0.6 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
0.1 | 0.7 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 0.6 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.1 | 0.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.4 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.5 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.1 | 2.5 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 1.2 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.1 | 0.1 | GO:0033058 | directional locomotion(GO:0033058) |
0.1 | 0.5 | GO:1904117 | cellular response to vasopressin(GO:1904117) |
0.1 | 8.8 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.1 | 0.8 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 1.4 | GO:0031167 | rRNA methylation(GO:0031167) |
0.1 | 0.9 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.1 | 0.3 | GO:0016598 | protein arginylation(GO:0016598) |
0.1 | 0.3 | GO:0001975 | response to amphetamine(GO:0001975) |
0.1 | 0.8 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.2 | GO:0032197 | transposition, RNA-mediated(GO:0032197) |
0.1 | 0.5 | GO:0022038 | corpus callosum development(GO:0022038) |
0.1 | 2.7 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.1 | 0.2 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
0.1 | 0.2 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.1 | 0.4 | GO:0090365 | regulation of mRNA modification(GO:0090365) negative regulation of mRNA modification(GO:0090367) |
0.1 | 0.3 | GO:0015695 | organic cation transport(GO:0015695) |
0.1 | 0.6 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.5 | GO:1990173 | protein localization to nuclear body(GO:1903405) positive regulation of establishment of protein localization to telomere(GO:1904851) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.1 | 0.4 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.3 | GO:0072177 | mesonephric duct development(GO:0072177) |
0.1 | 0.4 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
0.1 | 0.2 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
0.1 | 0.2 | GO:0034092 | negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
0.0 | 1.1 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 3.2 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 1.3 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.4 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.0 | 0.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.0 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.0 | 0.6 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.1 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.0 | 0.1 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.0 | 0.2 | GO:0060998 | regulation of dendritic spine development(GO:0060998) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
52.2 | 156.5 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
41.7 | 125.0 | GO:0098830 | presynaptic endosome(GO:0098830) |
28.7 | 86.1 | GO:0060187 | cell pole(GO:0060187) |
27.5 | 27.5 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
26.7 | 80.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
26.3 | 26.3 | GO:0044301 | climbing fiber(GO:0044301) |
24.0 | 143.7 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
21.6 | 259.8 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
20.5 | 204.9 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
19.7 | 59.2 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) GABA-ergic synapse(GO:0098982) |
18.6 | 296.9 | GO:0031045 | dense core granule(GO:0031045) |
17.5 | 105.0 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
16.1 | 80.4 | GO:0044316 | cone cell pedicle(GO:0044316) |
15.1 | 45.4 | GO:0090534 | longitudinal sarcoplasmic reticulum(GO:0014801) calcium ion-transporting ATPase complex(GO:0090534) |
14.9 | 402.0 | GO:0043194 | axon initial segment(GO:0043194) |
14.8 | 29.7 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
13.8 | 41.3 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
13.4 | 590.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
12.1 | 145.5 | GO:0032591 | dendritic spine membrane(GO:0032591) |
12.0 | 60.2 | GO:0098845 | postsynaptic endosome(GO:0098845) |
11.6 | 335.2 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
11.3 | 11.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
10.2 | 92.0 | GO:0030314 | junctional membrane complex(GO:0030314) |
9.8 | 420.6 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
9.5 | 217.6 | GO:1902710 | GABA receptor complex(GO:1902710) |
9.1 | 54.4 | GO:0005955 | calcineurin complex(GO:0005955) |
8.9 | 26.7 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
8.6 | 17.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
8.6 | 25.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
8.5 | 85.3 | GO:0005883 | neurofilament(GO:0005883) |
8.5 | 169.5 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
8.3 | 82.9 | GO:0033268 | node of Ranvier(GO:0033268) |
8.2 | 156.0 | GO:0032590 | dendrite membrane(GO:0032590) |
8.0 | 24.1 | GO:0097444 | spine apparatus(GO:0097444) |
7.9 | 15.9 | GO:0097453 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
7.5 | 568.3 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
7.3 | 7.3 | GO:1990812 | growth cone filopodium(GO:1990812) |
7.3 | 14.6 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
7.0 | 21.1 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
6.9 | 111.1 | GO:0097440 | apical dendrite(GO:0097440) |
6.7 | 33.3 | GO:0032280 | symmetric synapse(GO:0032280) |
6.6 | 26.3 | GO:0042583 | chromaffin granule(GO:0042583) |
6.4 | 89.9 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
6.3 | 43.8 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
6.2 | 43.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
5.8 | 986.0 | GO:0045211 | postsynaptic membrane(GO:0045211) |
5.8 | 17.4 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
5.8 | 5.8 | GO:0098855 | HCN channel complex(GO:0098855) |
5.7 | 22.7 | GO:0033269 | internode region of axon(GO:0033269) |
5.5 | 16.5 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
5.4 | 37.6 | GO:0097450 | astrocyte end-foot(GO:0097450) |
5.3 | 127.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
5.2 | 10.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
5.2 | 57.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
5.2 | 15.6 | GO:0005592 | collagen type XI trimer(GO:0005592) |
5.2 | 212.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
4.8 | 43.4 | GO:1990635 | proximal dendrite(GO:1990635) |
4.7 | 66.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
4.7 | 18.6 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
4.6 | 138.5 | GO:0097060 | synaptic membrane(GO:0097060) |
4.6 | 110.3 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
4.6 | 32.0 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
4.4 | 4.4 | GO:0098871 | postsynaptic actin cytoskeleton(GO:0098871) postsynaptic cytoskeleton(GO:0099571) |
4.1 | 149.2 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
4.1 | 304.9 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
4.1 | 105.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
4.0 | 55.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
4.0 | 23.7 | GO:0036449 | microtubule minus-end(GO:0036449) |
3.9 | 23.3 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
3.9 | 718.3 | GO:0030426 | growth cone(GO:0030426) |
3.7 | 11.1 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
3.7 | 33.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
3.7 | 29.3 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
3.7 | 18.3 | GO:0005927 | muscle tendon junction(GO:0005927) |
3.6 | 98.2 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
3.6 | 47.0 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
3.6 | 17.9 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
3.4 | 74.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
3.4 | 20.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
3.4 | 73.8 | GO:0043198 | dendritic shaft(GO:0043198) |
3.3 | 9.9 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
3.3 | 16.3 | GO:0005940 | septin ring(GO:0005940) |
3.2 | 9.7 | GO:0005960 | glycine cleavage complex(GO:0005960) |
3.2 | 16.1 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
3.2 | 622.6 | GO:0098793 | presynapse(GO:0098793) |
3.0 | 9.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
3.0 | 71.3 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
3.0 | 8.9 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
3.0 | 8.9 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
2.9 | 11.8 | GO:0097427 | microtubule bundle(GO:0097427) |
2.9 | 26.4 | GO:0005796 | Golgi lumen(GO:0005796) |
2.9 | 14.5 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
2.9 | 66.7 | GO:0043679 | axon terminus(GO:0043679) |
2.9 | 14.5 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
2.9 | 23.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
2.7 | 24.6 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
2.7 | 2.7 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
2.7 | 32.3 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
2.7 | 8.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
2.7 | 8.0 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
2.6 | 13.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
2.6 | 244.7 | GO:0043204 | perikaryon(GO:0043204) |
2.6 | 30.9 | GO:0070382 | exocytic vesicle(GO:0070382) |
2.5 | 2.5 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
2.4 | 14.6 | GO:0030904 | retromer complex(GO:0030904) |
2.4 | 7.2 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
2.3 | 4.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
2.3 | 29.4 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
2.2 | 28.5 | GO:0005871 | kinesin complex(GO:0005871) |
2.1 | 6.2 | GO:0045242 | mitochondrial isocitrate dehydrogenase complex (NAD+)(GO:0005962) isocitrate dehydrogenase complex (NAD+)(GO:0045242) |
2.0 | 128.7 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
2.0 | 12.1 | GO:0005787 | signal peptidase complex(GO:0005787) |
2.0 | 10.1 | GO:0070695 | FHF complex(GO:0070695) |
2.0 | 14.1 | GO:0031209 | SCAR complex(GO:0031209) |
2.0 | 4.0 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
2.0 | 11.8 | GO:0031527 | filopodium membrane(GO:0031527) |
1.9 | 5.8 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
1.9 | 5.8 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
1.9 | 121.5 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
1.9 | 17.3 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
1.9 | 1.9 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
1.8 | 5.4 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
1.8 | 62.5 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
1.8 | 10.7 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.7 | 10.4 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
1.7 | 164.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
1.7 | 5.1 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
1.7 | 6.7 | GO:0031105 | septin complex(GO:0031105) |
1.7 | 21.5 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
1.6 | 1.6 | GO:0030478 | actin cap(GO:0030478) |
1.6 | 13.1 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
1.6 | 4.8 | GO:0061574 | ASAP complex(GO:0061574) |
1.6 | 40.1 | GO:0097546 | ciliary base(GO:0097546) |
1.6 | 19.0 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.6 | 23.6 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
1.6 | 7.9 | GO:0030689 | Noc complex(GO:0030689) |
1.6 | 6.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
1.6 | 4.7 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
1.5 | 4.5 | GO:1902560 | GMP reductase complex(GO:1902560) |
1.5 | 6.0 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
1.5 | 226.6 | GO:0098794 | postsynapse(GO:0098794) |
1.5 | 77.0 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
1.4 | 18.7 | GO:0000124 | SAGA complex(GO:0000124) |
1.4 | 2.8 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
1.4 | 2.8 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
1.4 | 8.1 | GO:0030427 | site of polarized growth(GO:0030427) |
1.3 | 8.0 | GO:1990246 | uniplex complex(GO:1990246) |
1.3 | 46.0 | GO:0035869 | ciliary transition zone(GO:0035869) |
1.3 | 5.2 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
1.3 | 14.2 | GO:0060170 | ciliary membrane(GO:0060170) |
1.3 | 41.1 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
1.3 | 6.4 | GO:0097361 | CIA complex(GO:0097361) |
1.2 | 3.7 | GO:0030891 | VCB complex(GO:0030891) |
1.2 | 3.7 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
1.2 | 12.2 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
1.2 | 31.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
1.2 | 13.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
1.2 | 9.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
1.2 | 5.8 | GO:0035976 | AP1 complex(GO:0035976) |
1.1 | 8.0 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
1.1 | 79.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
1.1 | 27.0 | GO:0055038 | recycling endosome membrane(GO:0055038) |
1.1 | 159.5 | GO:0043209 | myelin sheath(GO:0043209) |
1.1 | 6.6 | GO:0071547 | piP-body(GO:0071547) |
1.1 | 2.2 | GO:0044292 | dendrite terminus(GO:0044292) |
1.1 | 12.8 | GO:0031932 | TORC2 complex(GO:0031932) |
1.1 | 11.7 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
1.1 | 29.6 | GO:0030315 | T-tubule(GO:0030315) |
1.0 | 6.2 | GO:0036157 | outer dynein arm(GO:0036157) |
1.0 | 22.6 | GO:0045335 | phagocytic vesicle(GO:0045335) |
1.0 | 1.0 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
1.0 | 10.0 | GO:0001891 | phagocytic cup(GO:0001891) |
1.0 | 10.8 | GO:0032982 | myosin filament(GO:0032982) |
1.0 | 8.8 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
1.0 | 3.9 | GO:0035363 | histone locus body(GO:0035363) |
0.9 | 39.9 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.9 | 3.8 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.9 | 6.5 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.9 | 2.8 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.9 | 21.4 | GO:0034707 | chloride channel complex(GO:0034707) |
0.9 | 5.5 | GO:0005869 | dynactin complex(GO:0005869) |
0.9 | 3.7 | GO:0072534 | perineuronal net(GO:0072534) |
0.9 | 16.4 | GO:0000145 | exocyst(GO:0000145) |
0.9 | 1.8 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.9 | 2.6 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.9 | 1.8 | GO:0016939 | kinesin II complex(GO:0016939) |
0.9 | 7.0 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.9 | 6.9 | GO:0030673 | axolemma(GO:0030673) |
0.9 | 3.4 | GO:1990745 | GARP complex(GO:0000938) EARP complex(GO:1990745) |
0.8 | 3.3 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.8 | 17.3 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.8 | 117.4 | GO:0045202 | synapse(GO:0045202) |
0.8 | 9.8 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.8 | 4.0 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.8 | 3.8 | GO:0048179 | activin receptor complex(GO:0048179) |
0.8 | 19.9 | GO:0005921 | gap junction(GO:0005921) |
0.8 | 5.3 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.7 | 15.7 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.7 | 2.2 | GO:0045025 | mitochondrial degradosome(GO:0045025) |
0.7 | 8.1 | GO:0044754 | autolysosome(GO:0044754) |
0.7 | 15.3 | GO:0055037 | recycling endosome(GO:0055037) |
0.7 | 4.9 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.7 | 4.7 | GO:0070652 | HAUS complex(GO:0070652) |
0.7 | 6.7 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.7 | 4.0 | GO:0060091 | kinocilium(GO:0060091) |
0.6 | 5.1 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.6 | 31.9 | GO:0031902 | late endosome membrane(GO:0031902) |
0.6 | 1.2 | GO:0071439 | clathrin complex(GO:0071439) |
0.6 | 34.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.6 | 2.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.6 | 113.8 | GO:0005874 | microtubule(GO:0005874) |
0.6 | 4.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.6 | 3.4 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.6 | 1.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.6 | 2.8 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.5 | 7.5 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.5 | 64.5 | GO:0043025 | neuronal cell body(GO:0043025) |
0.5 | 2.6 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.5 | 5.2 | GO:0051233 | spindle midzone(GO:0051233) |
0.5 | 1.5 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.5 | 1.0 | GO:0000125 | PCAF complex(GO:0000125) |
0.5 | 2.0 | GO:0070552 | BRISC complex(GO:0070552) |
0.5 | 10.3 | GO:0030133 | transport vesicle(GO:0030133) |
0.5 | 8.6 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.5 | 1.4 | GO:1990923 | PET complex(GO:1990923) |
0.5 | 1.4 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.5 | 1.9 | GO:0032044 | DSIF complex(GO:0032044) |
0.5 | 11.2 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.5 | 0.9 | GO:0031310 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
0.5 | 15.4 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.4 | 61.1 | GO:0005769 | early endosome(GO:0005769) |
0.4 | 1.7 | GO:0097196 | Shu complex(GO:0097196) |
0.4 | 3.3 | GO:0016272 | prefoldin complex(GO:0016272) |
0.4 | 1.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.4 | 9.5 | GO:0001533 | cornified envelope(GO:0001533) |
0.4 | 4.0 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.4 | 1.1 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.3 | 2.0 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.3 | 1.3 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.3 | 1.7 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.3 | 1.3 | GO:0070876 | SOSS complex(GO:0070876) |
0.3 | 2.5 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.3 | 1.8 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.3 | 3.9 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.3 | 1.8 | GO:0097255 | R2TP complex(GO:0097255) |
0.3 | 2.9 | GO:0005795 | Golgi stack(GO:0005795) |
0.3 | 1.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.3 | 2.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.3 | 0.8 | GO:0044194 | cytolytic granule(GO:0044194) |
0.3 | 3.6 | GO:0000801 | central element(GO:0000801) |
0.3 | 29.1 | GO:0030659 | cytoplasmic vesicle membrane(GO:0030659) |
0.3 | 0.8 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
0.2 | 1.0 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.2 | 2.7 | GO:0031201 | SNARE complex(GO:0031201) |
0.2 | 1352.0 | GO:0016021 | integral component of membrane(GO:0016021) |
0.2 | 2.0 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.2 | 0.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.2 | 3.4 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 5.9 | GO:0045171 | intercellular bridge(GO:0045171) |
0.2 | 0.4 | GO:0036398 | TCR signalosome(GO:0036398) |
0.2 | 0.5 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
0.2 | 2.1 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.2 | 1.4 | GO:0070993 | eukaryotic 43S preinitiation complex(GO:0016282) translation preinitiation complex(GO:0070993) |
0.2 | 0.8 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 0.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 1.7 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.1 | GO:0036117 | hyaluranon cable(GO:0036117) |
0.1 | 1.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 1.0 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 0.6 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.1 | 1.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.4 | GO:0000811 | GINS complex(GO:0000811) |
0.1 | 1.5 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 0.4 | GO:1990826 | nucleoplasmic periphery of the nuclear pore complex(GO:1990826) |
0.1 | 0.5 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 2.0 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 1.3 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.1 | 0.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 1.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.2 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.1 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.1 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.2 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.0 | 0.3 | GO:0001740 | Barr body(GO:0001740) |
0.0 | 0.0 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.0 | 0.1 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) dihydrolipoyl dehydrogenase complex(GO:0045240) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
41.7 | 166.9 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
41.6 | 166.5 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
40.7 | 162.6 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
39.1 | 156.5 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
32.8 | 98.5 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
31.4 | 94.1 | GO:0001847 | opsonin receptor activity(GO:0001847) |
28.4 | 113.4 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
27.7 | 110.7 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
26.5 | 106.0 | GO:0008486 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
24.8 | 173.8 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
24.0 | 143.7 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
21.8 | 152.8 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
21.5 | 150.8 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
19.4 | 136.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
19.3 | 57.9 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
18.3 | 146.8 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
18.3 | 109.7 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
17.8 | 88.8 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
15.7 | 47.2 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
14.4 | 57.7 | GO:0008489 | UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity(GO:0008489) |
13.7 | 96.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
13.0 | 52.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
13.0 | 116.9 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
12.8 | 64.0 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
12.6 | 113.7 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
12.6 | 75.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
12.2 | 36.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
12.2 | 60.9 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
12.0 | 120.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
11.8 | 59.1 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
11.8 | 35.5 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
11.8 | 82.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
11.8 | 70.5 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) |
11.7 | 46.9 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
11.6 | 34.9 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
11.6 | 34.7 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
11.5 | 57.7 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
11.2 | 89.4 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
11.2 | 33.5 | GO:0031997 | N-terminal myristoylation domain binding(GO:0031997) calcium ion binding involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099567) |
10.9 | 54.6 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
10.9 | 43.4 | GO:0033192 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) calmodulin-dependent protein phosphatase activity(GO:0033192) |
10.5 | 41.9 | GO:0016492 | G-protein coupled neurotensin receptor activity(GO:0016492) |
10.3 | 72.2 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
10.1 | 50.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
10.0 | 50.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
9.8 | 48.8 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
9.7 | 29.0 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
9.3 | 158.5 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
9.1 | 227.8 | GO:0016917 | GABA receptor activity(GO:0016917) |
9.1 | 27.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
8.9 | 26.8 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
8.7 | 251.2 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
8.3 | 41.7 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
8.3 | 24.8 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
8.1 | 48.8 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
7.9 | 750.3 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
7.8 | 23.4 | GO:0033222 | xylose binding(GO:0033222) |
7.7 | 146.8 | GO:0042166 | acetylcholine binding(GO:0042166) |
7.7 | 77.1 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
7.7 | 23.0 | GO:0008254 | 3'-nucleotidase activity(GO:0008254) |
7.5 | 60.3 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
7.4 | 44.7 | GO:0045503 | dynein light chain binding(GO:0045503) |
7.3 | 58.5 | GO:0032184 | SUMO polymer binding(GO:0032184) |
7.3 | 87.3 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
7.2 | 50.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
6.9 | 34.7 | GO:0070052 | collagen V binding(GO:0070052) |
6.9 | 48.5 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
6.8 | 20.4 | GO:0004084 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
6.5 | 25.9 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
6.4 | 32.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
6.3 | 18.9 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
6.1 | 18.3 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
6.1 | 6.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
6.1 | 24.3 | GO:0043404 | corticotrophin-releasing factor receptor activity(GO:0015056) corticotropin-releasing hormone receptor activity(GO:0043404) |
6.0 | 36.2 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
6.0 | 202.4 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
5.9 | 17.6 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
5.8 | 17.3 | GO:0001565 | phorbol ester receptor activity(GO:0001565) |
5.8 | 69.2 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
5.5 | 16.4 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
5.5 | 10.9 | GO:0016018 | cyclosporin A binding(GO:0016018) |
5.5 | 70.9 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
5.4 | 92.5 | GO:0015643 | toxic substance binding(GO:0015643) |
5.4 | 32.5 | GO:0001515 | opioid peptide activity(GO:0001515) |
5.3 | 42.6 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
5.2 | 31.1 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
5.1 | 61.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
5.1 | 15.4 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
5.1 | 61.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
5.1 | 50.8 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
5.1 | 101.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
5.0 | 44.6 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
4.8 | 14.3 | GO:0038100 | nodal binding(GO:0038100) |
4.7 | 14.1 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
4.7 | 18.6 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) |
4.6 | 13.7 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
4.5 | 76.9 | GO:0030955 | potassium ion binding(GO:0030955) |
4.5 | 22.6 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
4.5 | 27.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
4.5 | 22.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
4.5 | 35.8 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
4.4 | 13.3 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
4.3 | 43.3 | GO:1903136 | cuprous ion binding(GO:1903136) |
4.3 | 60.4 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
4.3 | 12.9 | GO:0102390 | mycophenolic acid acyl-glucuronide esterase activity(GO:0102390) |
4.1 | 41.4 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
4.1 | 20.7 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
4.1 | 12.4 | GO:0004359 | glutaminase activity(GO:0004359) |
4.0 | 12.1 | GO:0034485 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) |
4.0 | 20.1 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
4.0 | 52.1 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
4.0 | 27.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
4.0 | 257.0 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
3.9 | 15.7 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
3.9 | 7.8 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
3.9 | 11.6 | GO:2001070 | starch binding(GO:2001070) |
3.8 | 30.7 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
3.8 | 53.7 | GO:0051378 | serotonin binding(GO:0051378) |
3.8 | 3.8 | GO:0031208 | POZ domain binding(GO:0031208) |
3.8 | 88.1 | GO:0031489 | myosin V binding(GO:0031489) |
3.8 | 15.3 | GO:0005163 | nerve growth factor receptor binding(GO:0005163) |
3.8 | 7.7 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
3.8 | 7.6 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
3.8 | 18.8 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
3.8 | 37.5 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
3.7 | 190.8 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
3.6 | 18.2 | GO:0097016 | L27 domain binding(GO:0097016) |
3.6 | 10.9 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
3.6 | 391.9 | GO:0044325 | ion channel binding(GO:0044325) |
3.5 | 126.2 | GO:0046875 | ephrin receptor binding(GO:0046875) |
3.5 | 31.3 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
3.5 | 10.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
3.4 | 10.3 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
3.4 | 10.3 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
3.4 | 20.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
3.4 | 23.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
3.3 | 33.1 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
3.3 | 9.9 | GO:0035939 | microsatellite binding(GO:0035939) |
3.3 | 52.9 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
3.3 | 19.7 | GO:0015368 | calcium:sodium antiporter activity(GO:0005432) calcium:cation antiporter activity(GO:0015368) |
3.3 | 16.5 | GO:0008502 | melatonin receptor activity(GO:0008502) |
3.3 | 23.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
3.2 | 16.2 | GO:0030911 | TPR domain binding(GO:0030911) |
3.2 | 35.7 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
3.2 | 12.9 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
3.2 | 64.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
3.1 | 31.3 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
3.0 | 133.0 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
3.0 | 17.7 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
2.9 | 11.7 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
2.9 | 25.8 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
2.8 | 8.4 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
2.8 | 11.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
2.8 | 8.3 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
2.7 | 10.9 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
2.7 | 8.2 | GO:0008142 | oxysterol binding(GO:0008142) |
2.7 | 32.1 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
2.7 | 2.7 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
2.7 | 8.0 | GO:0016015 | morphogen activity(GO:0016015) |
2.7 | 18.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
2.7 | 29.3 | GO:0004017 | adenylate kinase activity(GO:0004017) |
2.6 | 15.8 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
2.5 | 93.9 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
2.5 | 17.7 | GO:0046870 | cadmium ion binding(GO:0046870) |
2.5 | 7.6 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
2.5 | 7.5 | GO:0031780 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
2.5 | 2.5 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
2.4 | 14.7 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
2.4 | 29.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
2.4 | 4.8 | GO:0097677 | STAT family protein binding(GO:0097677) |
2.4 | 12.0 | GO:0001155 | TFIIIA-class transcription factor binding(GO:0001155) |
2.4 | 14.4 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
2.4 | 12.0 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
2.4 | 7.2 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
2.4 | 16.7 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
2.4 | 7.2 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
2.3 | 9.4 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
2.3 | 2.3 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
2.3 | 9.3 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
2.3 | 11.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
2.3 | 16.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
2.3 | 9.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
2.3 | 6.9 | GO:0051425 | PTB domain binding(GO:0051425) |
2.3 | 9.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
2.2 | 24.7 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
2.2 | 6.6 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
2.2 | 15.4 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
2.2 | 4.4 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
2.2 | 56.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
2.1 | 21.5 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
2.1 | 10.7 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
2.1 | 15.0 | GO:0001849 | complement component C1q binding(GO:0001849) |
2.1 | 31.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
2.1 | 116.2 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
2.1 | 35.9 | GO:0031005 | filamin binding(GO:0031005) |
2.0 | 10.2 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
2.0 | 6.1 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
2.0 | 10.0 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
2.0 | 41.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
2.0 | 7.9 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
2.0 | 25.7 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
2.0 | 27.6 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
2.0 | 19.6 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
2.0 | 7.8 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.9 | 5.8 | GO:0042731 | PH domain binding(GO:0042731) |
1.9 | 11.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
1.9 | 1.9 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
1.9 | 67.3 | GO:0035254 | glutamate receptor binding(GO:0035254) |
1.9 | 9.3 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
1.8 | 3.7 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
1.8 | 9.2 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
1.8 | 3.7 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
1.8 | 29.1 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
1.8 | 5.4 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
1.8 | 87.2 | GO:0019894 | kinesin binding(GO:0019894) |
1.8 | 5.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
1.8 | 8.8 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
1.7 | 17.5 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
1.7 | 7.0 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
1.7 | 20.9 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
1.7 | 7.0 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
1.7 | 8.7 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
1.7 | 8.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
1.7 | 16.9 | GO:0033691 | sialic acid binding(GO:0033691) |
1.7 | 3.4 | GO:0045550 | geranylgeranyl reductase activity(GO:0045550) |
1.7 | 5.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.7 | 6.7 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.7 | 26.7 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
1.6 | 51.1 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
1.6 | 19.8 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
1.6 | 9.9 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
1.6 | 13.1 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
1.6 | 39.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
1.6 | 6.5 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
1.6 | 6.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
1.5 | 10.8 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
1.5 | 139.1 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
1.5 | 35.1 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
1.5 | 10.6 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
1.5 | 4.5 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
1.5 | 4.5 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
1.5 | 25.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
1.5 | 19.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
1.5 | 10.5 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
1.5 | 10.4 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
1.5 | 5.9 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
1.5 | 4.4 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
1.5 | 10.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
1.5 | 5.8 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.4 | 5.8 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
1.4 | 10.0 | GO:0050811 | GABA receptor binding(GO:0050811) |
1.4 | 2.9 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
1.4 | 8.4 | GO:0043426 | MRF binding(GO:0043426) |
1.4 | 30.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
1.4 | 11.0 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
1.4 | 16.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
1.4 | 9.6 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
1.3 | 5.4 | GO:0001032 | RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
1.3 | 4.0 | GO:0080130 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
1.3 | 9.2 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
1.3 | 2.6 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
1.3 | 3.9 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
1.3 | 21.9 | GO:0097602 | cullin family protein binding(GO:0097602) |
1.3 | 6.3 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
1.3 | 7.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
1.3 | 5.0 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
1.2 | 19.9 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
1.2 | 12.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
1.2 | 6.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
1.2 | 10.9 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
1.2 | 22.9 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
1.2 | 17.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
1.2 | 7.1 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
1.2 | 4.7 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
1.1 | 18.1 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
1.1 | 11.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
1.1 | 5.6 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
1.1 | 29.0 | GO:0030507 | spectrin binding(GO:0030507) |
1.1 | 5.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.1 | 49.7 | GO:0019003 | GDP binding(GO:0019003) |
1.1 | 14.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
1.1 | 7.6 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
1.1 | 35.8 | GO:0051018 | protein kinase A binding(GO:0051018) |
1.1 | 4.3 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.1 | 5.4 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
1.1 | 17.3 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
1.1 | 7.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
1.1 | 3.2 | GO:0019002 | GMP binding(GO:0019002) |
1.0 | 3.1 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
1.0 | 8.4 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
1.0 | 13.5 | GO:0008061 | chitin binding(GO:0008061) |
1.0 | 3.1 | GO:0016429 | tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
1.0 | 26.3 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
1.0 | 276.4 | GO:0015631 | tubulin binding(GO:0015631) |
1.0 | 5.0 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
1.0 | 4.0 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
1.0 | 8.0 | GO:0005272 | sodium channel activity(GO:0005272) |
1.0 | 13.8 | GO:0005522 | profilin binding(GO:0005522) |
1.0 | 25.6 | GO:0030546 | receptor activator activity(GO:0030546) |
1.0 | 8.8 | GO:0015266 | protein channel activity(GO:0015266) |
1.0 | 1.9 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
1.0 | 2.9 | GO:0016403 | dimethylargininase activity(GO:0016403) |
1.0 | 3.9 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
1.0 | 4.8 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
1.0 | 34.6 | GO:0015485 | cholesterol binding(GO:0015485) |
0.9 | 153.9 | GO:0003924 | GTPase activity(GO:0003924) |
0.9 | 9.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.9 | 16.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.9 | 13.7 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.9 | 3.6 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.9 | 12.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.9 | 22.9 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.9 | 5.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.9 | 6.1 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.9 | 4.3 | GO:0001729 | ceramide kinase activity(GO:0001729) |
0.9 | 3.4 | GO:1990955 | G-rich single-stranded DNA binding(GO:1990955) |
0.8 | 3.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.8 | 33.8 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.8 | 5.9 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.8 | 1.7 | GO:0070401 | NADP+ binding(GO:0070401) |
0.8 | 20.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.8 | 1.7 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.8 | 2.5 | GO:0034512 | box C/D snoRNA binding(GO:0034512) |
0.8 | 2.5 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.8 | 5.7 | GO:0051998 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.8 | 6.4 | GO:0016594 | glycine binding(GO:0016594) |
0.8 | 4.8 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.8 | 5.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.8 | 3.9 | GO:0070404 | NADH binding(GO:0070404) |
0.8 | 6.0 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.8 | 5.3 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.7 | 3.7 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.7 | 6.0 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.7 | 3.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.7 | 23.4 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.7 | 5.8 | GO:0048156 | tau protein binding(GO:0048156) |
0.7 | 8.6 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.7 | 24.3 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.7 | 17.8 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.7 | 2.1 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.7 | 17.1 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.7 | 22.6 | GO:0005262 | calcium channel activity(GO:0005262) |
0.7 | 6.8 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.7 | 5.4 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.7 | 2.0 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.7 | 1.3 | GO:0042806 | fucose binding(GO:0042806) |
0.7 | 2.0 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.6 | 2.6 | GO:0016672 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
0.6 | 2.6 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.6 | 1.8 | GO:0004096 | catalase activity(GO:0004096) |
0.6 | 19.9 | GO:0008009 | chemokine activity(GO:0008009) |
0.6 | 1.8 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.6 | 1.8 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.6 | 2.9 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.6 | 10.5 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.6 | 1.7 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.6 | 8.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.6 | 5.7 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.6 | 1.7 | GO:0005135 | erythropoietin receptor binding(GO:0005128) interleukin-3 receptor binding(GO:0005135) |
0.6 | 2.8 | GO:0035240 | dopamine binding(GO:0035240) |
0.6 | 3.9 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.5 | 3.8 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.5 | 7.4 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.5 | 2.6 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.5 | 5.8 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.5 | 119.7 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.5 | 38.7 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.5 | 2.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.5 | 4.0 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.5 | 1.5 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.5 | 3.5 | GO:0019808 | polyamine binding(GO:0019808) |
0.5 | 5.0 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.5 | 6.9 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.5 | 6.4 | GO:0003796 | lysozyme activity(GO:0003796) |
0.5 | 10.7 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.5 | 6.3 | GO:0070403 | NAD+ binding(GO:0070403) |
0.5 | 7.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.5 | 1.4 | GO:0019961 | interferon binding(GO:0019961) |
0.5 | 8.7 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.5 | 52.3 | GO:0005179 | hormone activity(GO:0005179) |
0.5 | 5.9 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.5 | 2.3 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.4 | 15.4 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.4 | 10.9 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.4 | 1.7 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.4 | 3.4 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.4 | 1.2 | GO:0004781 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.4 | 1.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.4 | 8.3 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.4 | 1.2 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.4 | 0.4 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.4 | 2.6 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.4 | 1.5 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.4 | 0.7 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.4 | 19.8 | GO:0003774 | motor activity(GO:0003774) |
0.4 | 2.9 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.4 | 2.5 | GO:0030506 | ankyrin binding(GO:0030506) |
0.3 | 3.1 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.3 | 2.4 | GO:0008430 | selenium binding(GO:0008430) |
0.3 | 2.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.3 | 1.9 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.3 | 1.3 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.3 | 15.8 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.3 | 2.2 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.3 | 1.6 | GO:0089720 | caspase binding(GO:0089720) |
0.3 | 1.3 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.3 | 0.6 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.3 | 0.9 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.3 | 6.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.3 | 4.1 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.3 | 2.6 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.3 | 0.6 | GO:0004040 | amidase activity(GO:0004040) |
0.3 | 5.6 | GO:0004407 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
0.3 | 0.8 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
0.3 | 1.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.3 | 1.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.3 | 1.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.3 | 16.5 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.3 | 4.3 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.2 | 1.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 1.0 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.2 | 1.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.2 | 0.7 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.2 | 23.0 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.2 | 7.2 | GO:0000149 | SNARE binding(GO:0000149) |
0.2 | 1.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) diacylglycerol O-acyltransferase activity(GO:0004144) |
0.2 | 5.1 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.2 | 3.0 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 9.3 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.2 | 3.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 1.9 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.2 | 2.7 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.2 | 0.8 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.2 | 0.6 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.2 | 1.3 | GO:0016918 | retinal binding(GO:0016918) |
0.2 | 15.8 | GO:0005525 | GTP binding(GO:0005525) |
0.2 | 2.8 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.2 | 0.5 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.2 | 0.5 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.2 | 8.7 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.2 | 0.6 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.2 | 0.5 | GO:0004825 | methionine-tRNA ligase activity(GO:0004825) |
0.2 | 0.6 | GO:0043532 | angiostatin binding(GO:0043532) |
0.2 | 1.4 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.7 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 1.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.8 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.8 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 0.8 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.4 | GO:0000827 | inositol-1,3,4,5,6-pentakisphosphate kinase activity(GO:0000827) |
0.1 | 0.6 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.6 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.7 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 0.2 | GO:0070976 | TIR domain binding(GO:0070976) |
0.1 | 4.3 | GO:0070330 | aromatase activity(GO:0070330) |
0.1 | 0.4 | GO:1903763 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
0.1 | 3.9 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 2.3 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 0.7 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 49.1 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 1.6 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.6 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 1.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.3 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.1 | 0.5 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 1.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.2 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 0.3 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 0.4 | GO:0005267 | potassium channel activity(GO:0005267) |
0.0 | 0.2 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 0.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.2 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
18.3 | 18.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
10.4 | 156.5 | PID S1P S1P4 PATHWAY | S1P4 pathway |
9.2 | 192.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
6.9 | 254.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
5.6 | 39.4 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
5.6 | 5.6 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
4.8 | 110.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
4.0 | 28.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
3.3 | 33.1 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
3.0 | 15.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
2.6 | 65.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
2.4 | 80.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
2.4 | 33.8 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
2.1 | 122.2 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
1.9 | 69.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
1.7 | 38.0 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
1.7 | 92.9 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
1.6 | 70.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
1.6 | 66.0 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
1.6 | 49.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
1.5 | 37.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
1.5 | 1.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
1.5 | 3.0 | PID IFNG PATHWAY | IFN-gamma pathway |
1.4 | 10.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
1.3 | 34.6 | PID CONE PATHWAY | Visual signal transduction: Cones |
1.3 | 28.7 | PID RAS PATHWAY | Regulation of Ras family activation |
1.3 | 200.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
1.1 | 10.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
1.0 | 10.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.9 | 8.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.8 | 2.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.8 | 4.6 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.7 | 3.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.6 | 12.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.6 | 19.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.5 | 8.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.5 | 3.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.5 | 14.1 | PID AURORA A PATHWAY | Aurora A signaling |
0.5 | 7.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.4 | 4.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.4 | 1.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.4 | 16.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.4 | 127.5 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.4 | 5.0 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.4 | 6.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.3 | 2.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 4.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 1.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 2.5 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 1.8 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.2 | 0.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 2.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 1.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 0.9 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 0.4 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.7 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 0.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 3.1 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
17.7 | 265.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
17.6 | 264.7 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
13.5 | 703.1 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
12.6 | 214.8 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
11.5 | 207.2 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
11.4 | 216.0 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
10.2 | 255.5 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
9.7 | 174.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
9.7 | 125.5 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
9.0 | 224.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
8.6 | 190.1 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
8.2 | 98.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
7.0 | 91.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
7.0 | 77.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
6.8 | 292.3 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
6.5 | 207.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
6.1 | 153.6 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
6.0 | 12.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
6.0 | 173.8 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
5.5 | 76.6 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
5.4 | 97.9 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
5.3 | 21.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
5.1 | 61.7 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
5.1 | 61.4 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
4.5 | 109.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
4.2 | 46.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
4.2 | 78.9 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
4.0 | 106.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
3.8 | 53.0 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
3.7 | 206.6 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
3.5 | 118.9 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
3.4 | 54.5 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
3.0 | 27.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
2.9 | 73.0 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
2.9 | 51.5 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
2.7 | 21.8 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
2.7 | 13.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
2.6 | 44.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
2.6 | 38.9 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
2.5 | 22.8 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
2.3 | 37.6 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
2.3 | 34.6 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
2.3 | 6.8 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
2.3 | 22.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
2.2 | 33.5 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
2.1 | 20.8 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
1.9 | 50.7 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
1.9 | 32.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
1.8 | 33.1 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
1.8 | 168.2 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
1.8 | 16.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
1.6 | 9.5 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
1.4 | 26.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
1.4 | 7.2 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
1.4 | 20.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
1.3 | 40.1 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
1.3 | 9.0 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
1.2 | 36.7 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
1.2 | 7.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
1.2 | 11.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
1.2 | 5.8 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
1.2 | 2.3 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
1.2 | 17.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
1.1 | 13.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
1.0 | 17.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
1.0 | 9.9 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
1.0 | 15.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.0 | 22.1 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.9 | 4.7 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.9 | 11.3 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.9 | 3.8 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.9 | 12.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.9 | 159.5 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.9 | 12.0 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.8 | 70.1 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.8 | 15.5 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.8 | 8.8 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.8 | 13.0 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.8 | 14.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.7 | 3.0 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.7 | 57.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.7 | 7.9 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.7 | 8.6 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.6 | 11.8 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.6 | 15.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.6 | 15.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.6 | 1.1 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.5 | 8.0 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.4 | 4.0 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.4 | 11.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.4 | 1.3 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.4 | 4.1 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.4 | 2.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.4 | 8.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.4 | 13.0 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.4 | 2.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.3 | 1.7 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.3 | 4.8 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.3 | 6.5 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.3 | 10.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.3 | 20.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.3 | 1.2 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.2 | 1.9 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.2 | 3.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 0.4 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.2 | 2.0 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.2 | 1.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 2.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 2.5 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 1.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 1.5 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 0.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.5 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 0.6 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.2 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |